Pathophysiological pro-inflammatory and pain-inducing mechanisms in degenerative intervertebral discs by Poveda, Lucy
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.uzh.ch
Year: 2008
Pathophysiological Pro-Inflammatory and Pain-Inducing
Mechanisms in Degenerative Intervertebral Discs
Poveda, L
Poveda, L. Pathophysiological Pro-Inflammatory and Pain-Inducing Mechanisms in Degenerative Intervertebral
Discs. 2008, University of Zurich, Faculty of Science.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
University of Zurich, Faculty of Science, 2008.
Poveda, L. Pathophysiological Pro-Inflammatory and Pain-Inducing Mechanisms in Degenerative Intervertebral
Discs. 2008, University of Zurich, Faculty of Science.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
University of Zurich, Faculty of Science, 2008.
Pathophysiological Pro-Inflammatory and Pain-Inducing 
Mechanisms in Degenerative Intervertebral Discs 
 
Dissertation 
zur 
Erlangung der naturwissenschaftlichen Doktorwürde 
(Dr.sc.nat.) 
vorgelegt der 
Mathematisch-naturwissenschaftlichen Fakultät 
der 
 
          Universität Zürich 
 
von 
 
 
Lucy Poveda 
aus 
Grossbritannien 
 
     Promotionskomitee 
Prof. Dr. Norbert Boos (Leiter der Dissertation) 
Prof. Dr. Dr. Michael O. Hottiger (Vorsitz) 
Prof. Dr. Roland Wenger 
 
   Zürich, 2008 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2
 TABLE OF CONTENTS 
 
SUMMARY..………………………………………………………………………………..5 
 
ZUSAMMENFASSUNG…………………………………………………………………..6 
 
ABBREVIATIONS…………………………………………………………………………7 
 
INTRODUCTION…………………………………………………………………………..9 
 
1. The human Intervertebral Disc (IVD)……………………………………………………………………9 
1.1. The spine…………………………………………………………………………………………9 
1.2. The healthy IVD…………..…..………………………………………………………………….9 
1.2.1. IVD composition and constituents…………………………………………………..11 
1.2.2. IVD Physiology……………………………………………………………………...13 
1.3. Age-related (degenerative) changes in the IVD…………………………………………………15 
1.3.1. Aetiology of age-related (degenerative) changes of the IVD………………………..16 
1.3.2. Phenotypic and cellular alterations…………………………………………………..17 
1.3.3. Extracellular matrix (ECM) changes…………………………………………………18 
1.3.4. Cellular and ECM modulation by cytokines and growth factors…………………….20 
1.3.5. Oxidative stress…………….………………………………………………………...22 
1.3.6. Consequences of age-related (degenerative) changes………………………………..24 
 1.4. Clinical relevance: Low back-pain and IVD degeneration………………………………………25 
1.5. Experimental models……………………………………………………….................................27 
1.5.1. In vitro models………………………………………………………………………..27 
1.5.2. In vivo models………………………………………………………………………...28 
 
2. Nuclear factor-kappaB (NF-κB)…………………………………………………………………………..30 
2.1. The mammalian NF-κB family members……………………………………..............................30 
2.2. NF-κB signalling pathways……………………………………………………………………...32 
 
3. Regulation of NF-κB……………………………………………………………………………………….36 
3.1. Degradation of specific IκB proteins………………………………………………….…………36 
3.2. NF-κB dimmers and binding to κB sites……………………………………………….………..37 
3.3. NF-κB transcriptional co-regulators…………………………………………………….……….38 
3.4. Post translational modifications of NF-κB………………………………………………………40 
 3.5. Epigenetic regulation of NF-κB …………………………………………………………………42 
3.6. Receptors/signalling cascades …………………………….……………………………………..44 
 
4. Aim of Thesis………………………………………………………………………………………………46 
 
RESULTS…………………………………………………………………………………48 
 
5. Research articles……………………………………………………………………………………………48 
5.1. Role of N-(carboxymethyl) lysine modifications in NF-κB translocation and   MMP-13 gene 
expression in bovine nucleus pulposus cells………………………………………………………….49 
5.2. Peroxynitrite induces gene expression in human intervertebral disc cells………………………75 
 
6. Unpublished results………………………………………………………………………………………..98 
6.1. Environmental condition-dependent accumulation of N-(carboxymethyl) lysine (CML) and 
expression of RAGE (receptor for glycation end products) in a chondrons-based pellet culture system 
of bovine nucleus pulposus cells………………………………………….……..................................98 
 3
 6.1.1. Introduction and aim………………………………………………………………….98 
6.1.2. Results………..………………………………………………………………………99 
6.1.3. Materials and methods …………………………………………………….………..111 
6.2. Detection of RAGE at protein and gene level………………………………………………….114 
6.2.1. Introduction and aim………………………………………………………………..114 
6.2.2. Results………………………………………………………………………………114 
6.2.3. Materials and methods………………………………………………………………116 
6.3. NGF in the intervertebral disc….……………………………………………………………….116 
6.3.1. Introduction and aim………………………………………………………………...116 
6.3.2. Results……………………………………………………………..………………..117 
6.3.3. Materials and methods………………………………………………………………118 
6.4. Influence of hypoxia (0.2% oxygen), low pH (6.7) and SIN-1 on bovine NP cells……………118  
6.4.1. Introduction and aim……………………………………………………….………..118 
6.4.2. Results………………………………………………………………………………119 
6.4.3. Materials and methods………………………………………………………………121 
6.5. Effects of short and long-term peroxynitrite stimulation in nuclear shuttling of NF-κB/p65 in 
human NP cells……………………………………………………………………………………...122 
 6.5.1. Introduction and aim………………………………………………………………..122 
6.5.2. Results………………………………………………………….………….………..122 
6.5.3. Materials and methods………………………………………………….…….……..123 
6.6. Human telomerase reverse transcriptase (hTERT) in NP cells……………………….………..124 
6.6.1. Introduction and aim……………………………………………………….……….124 
6.6.2. Lentivirus containing hTERT………………………………………………….……125 
6.6.3. Results……………………………………………………………............................126 
 
 
DISCUSSION……………………………………………………………………………127 
 
7. Summary of results……………………………………………………………………………………….127 
 
8. The chondron-pellet culture system……………………………………………………………………..129 
 8.1. Use and limitations……………………………………………………………………………..129 
 8.2. Perspectives…………………………………………………………………………………….132 
 
9. Role of AGEs in disc matrix homeostasis and remodelling processes…………………………………133 
9.1. ECM remodelling……………………………………………………………………………….133 
9.2. Perspectives……………………………………………………………………………………..134 
 
10. Peroxynitrite induces cytokine gene expression in human IVD cells………………………………...136 
10.1. Peroxynitrite and the activation of an alternative NF-κB signalling pathway………………...136 
10.2.Target genes of peroxynitrite ………………………………………………………………….137 
10.3. Perspectives……………………………………………………………………………………137 
 
 
REFERENCES………………………………………………………………………….139 
 
CURRICULUM VITAE…………………………………………………………………159 
 
ACKNOWLEDGEMENTS……………………………………………………………..160
 4
                                                                                                                                                                  Summary 
SUMMARY 
The intervertebral disc (IVD) is thought to be the source of specific back pain as it 
exhibits distinct age-related (degenerative) alterations. A compromised nutrition can cause 
serious cellular and tissue stress altering the phenotype of IVD cells and their embedding 
extracellular matrix (ECM). These alterations can be mediated partly by oxidative stress 
which involves post-translational protein modifications at cellular and ECM level in the 
IVD. Such modifications include the deposition of advanced glycation end-products (AGE) 
and tyrosine nitration mediated by the highly oxidising agent peroxynitrite. Their presence 
or accumulation can potentially affect a vast number of cellular processes ranging from pro-
inflammatory signalling cascades to a disruption of tissue homeostasis. Nuclear factor κB 
(NF-κB) is a transcription factor that regulates the expression of hundreds of target genes in 
response to numerous stimuli. However, aberrant regulation of NF-κB is associated with 
many inflammatory and degenerative diseases.  
The aim of this thesis was to elucidate the physiological impact of oxidative stress in terms 
of AGE and tyrosine nitration in cells from the nucleus pulposus (NP), centre of the IVD; 
both of which induced nuclear translocation of the large subunit of NF-κB i.e. p65(RelA) in 
NP cells. The activated targeted genes varied according to the stimuli. AGE induced MMP-
13 expression implying a role in matrix remodelling, whereas peroxynitrite as the source of 
tyrosine nitration induced a pro-inflammatory response involving a prolonged p65(RelA) 
nuclear shuttling. Taken together, these results imply that NF-κB activation plays a key role 
and can potentially influence ageing/degeneration processes in the IVD through AGE 
accumulation or peroxynitrite action. 
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                                                                                                                                                   Zusammenfassung 
ZUSAMMENFASSUNG 
Die Bandscheibe durchläuft mit zunehmendem Alter degenerative Veränderungen, die an 
der Entstehung von Rückenschmerzen beteiligt zu sein scheinen. Die kompromittierte 
Ernährung in der Bandscheibe kann schwerwiegenden Stress in Zellen und Gewebe 
auslösen, der zu Veränderungen im Phänotyp der Zellen und in der extrazellulären Matrix 
führen kann. Diese Veränderungen können auf oxidativem Stress basieren und zu 
posttranslationalen Proteinmodifikationen in Zellen und Matrix führen, z.B. zur  Bildung 
von Advanced Glycation End Products (AGE) oder zur Nitrierung von Tyrosin durch 
Peroxynitrit. Die Anreicherung dieser Produkte kann u.a. eine proinflammatorische 
Kaskade aktivieren oder das Gleichgewicht im Gewebeumbau stören. Der nukleare Faktor 
kB (NF-kB) ist ein Transkriptionsfaktor, der die Expression vieler Gene reguliert und mit 
einer Vielzahl inflammatorischen und degenerativer Erkrankungen verknüpft ist. 
Das Ziel dieser Doktorarbeit war es die physiologischen Auswirkungen von oxidativen 
Stress (und damit das Vorkommen von AGE und die Nitrierung von Tyrosin) auf die Zellen 
der inneren Bandscheibenregion (Nukleus Pulposus) zu untersuchen. 
Sowohl das Vorkommen von AGE, als auch die Nitrierung von Tyrosin führt in den Zellen 
des Nukleus Pulposus zur nuklearen Translokation der grossen Untereinheit von Nf-kB (= 
p65 = RelA). Die aktivierten Zielgene variierten hierbei je nach Stimuli: AGE induzierte die 
Genexpression von MMP-13 (was auf eine Bedeutung im Matrixumbau hindeutet), 
während Peroxynitrit eine proinflammatorische Reaktion verursachte, die mit einer 
anhaltender Verschiebung von p65 in den Zellkern einherging. Dies Ergebnisse zeigen, dass 
sowohl AGE als auch Peroxynitrit in der altersbedingten Veränderung der Bandscheibe eine 
Rolle spielen könnte.    
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                                                                                                                                                          Abbreviations 
ABBREVIATIONS 
 
 
ADAMTS   A disintegrin and metalloproteinase with thrombospondin motifs 
AF    Annulus fibrosus 
AGE   Advanced glycation end products 
BAFF    B-cell activating factor 
C-terminal   Carboxy-terminal 
CARM   Coactivator-associated arginine methyltransferase 
CBP   CREB-binding protein 
CILP    Cartilage intermediate layer protein 
CML   N-(carboxymethyl)lysine 
CoA   Coenzyme A 
DNA   Deoxyribonucleic acid 
ECM    Extracellular matrix 
EP    Endplate 
GAG    Glycosaminoglycan 
HAT   Histone acetyltransferase 
HDAC   Histone deacetylase 
IC    Intracellular 
IκB    Inhibitory κB  
IKK    IκB kinase complex 
IL    Interleukin 
IVD    Intervertebral disc 
LBP   Low back pain 
LTβ    Lymphotoxin β  
LPS   Lipopolysaccharide 
MDa   Megadalton 
MMP    Matrix metalloproteinase 
MSK   Mitogen- and stress-activated kinase 
NEMO   NF-κB essential modulator 
NF-κB    Nuclear factor-kappaB 
NGF    Nerve growth factor 
NIK   NF-κB-inducing kinase 
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                                                                                                                                                          Abbreviations 
NLS   Nuclear localisation sequence 
NO    Nitric oxide 
NP    Nucleus pulposus 
N-terminal  Amino-terminal 
PAGE   Polyacrylamide gel electrophoresis 
P/CAF   p300/CBP associated factor 
PAMPs   pathogen-associated molecular patterns 
PARP-1  Poly (ADP-ribose)polymerase-1 
PCM    Pericellular matrix 
PCR   Polymerase chain reaction 
PKA   Protein kinase A 
PGE2    Prostaglandin E2 
PLA2    Phospholipase A2 
PRMT   Protein arginine methyltransferase 
P-TEFb   Positive transcription elongation factor b 
RNA   Ribonucleic acid 
RHD    Rel homology domain 
RPS3   Ribosomal protein 3 
RT-PCR  Reverse transcriptase polymerase chain reaction 
SDS   Sodium dodecyl sulphate 
SIN-1   3-Morpholinosydnonimine hydrochloride 
SRC   Steroid receptor co-activator 
TAD    Transcription activation domain 
TAF   TBP-associated factor 
TBP   TATA-binding protein 
TGF    Transforming growth factor 
TIMP    Tissue inhibitory metalloproteinase 
TLR   Toll-like receptor 
TNF    Tumour necrosis factor 
TNFR   Tumour necrosis factor receptor 
TRADD  TNF receptor-associated death domain 
TRAF   TNF receptor-associated factor 
UV   Ultraviolet 
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                                                                                                                                                             Introduction 
INTRODUCTION 
 
1. The human intervertebral disc 
 
1.1. The spine 
The spine is a multi-segmented column composed of 24 individual vertebrae plus 
the sacrum, which can be divided into four regions: cervical, thoracic, lumbar and sacral. 
The main features of the cervical and lumbar spine are their mobility in these regions and 
their ability to bear substantial loads, whereas the thoracic spine is less mobile as it forms 
part of the ribcage. The sacrum is composed of five fused vertebrae and the coccygis 
consists of four fused vertebrae. The sacrum articulates with the pelvis at the sacroiliac 
joints [1]. The basic functional unit of the spine is referred to as the ‘spinal unit’ or ‘motion 
segment’ which displays the typical mechanical features of the entire spine. This so-called 
three joint complex, consists of two adjacent vertebrae separated by the intervertebral disc 
(IVD) anteriorly and the bilateral facet joints posteriorly. The vertebrae are further 
connected by spinal ligaments, joint capsules and segmental muscles.  
The spine provides stability and mobility to the body and ensures protection to nerve roots 
and the spinal cord, consequently, its function relies fully on the integrity and interplay of 
its constituents. 
 
1.2. The healthy intervertebral disc (IVD) 
The IVD is a highly specialised tissue that lies between the vertebral bodies. The 
human IVD consists of three distinct regions: a cartilaginous endplate (EP), the annulus 
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fibrosus (AF) and the nucleus pulposus (NP) with a transitional zone which merges the 
latter two regions. Proper biomechanical and biological interaction between the AF and the 
NP enables the disc to perform various functions; such as bending, flexibility, load 
distribution, and shock absorption.  IVDs represent one third of the height of the spine [2, 
3], for instance,  the IVD of the lumbar spine has an approximate radius of 20 mm and a 
thickness of 7-10 mm.  
The morphology of disc cells varies across the tissue from a fibroblast-like (ellipsoidal) to 
chondrocyte-like (round) phenotype in the AF to NP respectively. Adult disc cells represent 
approximately 1% of the disc volume and are responsible for producing and maintaining the 
extracellular matrix (ECM) in which they are embedded [4]. The ECM composition also 
varies across the IVD according to its specific function. There is a predominant gradient of 
collagen types I and II across the disc. Collagen type I is predominantly encountered in the 
AF and decreases in concentration towards the transition zone. Collagen type II instead is 
highly predominant in the NP and decreases progressively in density towards the AF [5]. 
Matrix maintenance and homeostasis are highly dynamic processes as the ECM is 
constantly being remodelled leading to a fine tuning between anabolic and catabolic 
processes. Homeostasis is essential in procuring an adaptational response to changing 
environments. The interplay that enables homeostasis consists of ECM degradative 
enzymes such as matrix metalloproteinases (MMPs) and aggrecanases (like ADAMTs) as 
well as their corresponding inhibitors. In addition, all enzymes and inhibitors seem to be 
synthesised by disc cells themselves [6].  
 
 10
                                                                                                                                                             Introduction 
           
   A               B 
Figure 1. Intervertebral disc specimens showing the extreme course of ageing in a motion segment of the 
lumbar spine. A) A sagittal section through the lumbar spine of a 14-year-old infant shows a clear distinction 
between the nucleus pulposus (NP) and the annulus fibrosus (AF). The cartilaginous endplates (EPs) are 
composed of a thick layer of hyaline cartilage. The vertebral bodies show rounded edges. B) Conversely, the 
specimen corresponding to a 70-year-old individual possesses a completely collapsed disc, no distinction 
between the components of the motion segment is observed. The cartilage enplates are partially resorbed and 
exhibit severe sclerotic alterations (Courtesy Prof. Boos). 
 
 
1.2.1. IVD composition and constituents 
The annulus fibrosus (AF) is a densely organised structure containing approximately 
20 concentric rings. These consist mainly of collagen type I fibril sheets or lamellae which 
are parallel to the circumferences of the disc, thereby, surrounding the NP. The lamellae are 
perpendicular in direction to one another and ellipsoidal cells are embedded within this 
structure. These cells have their major radii aligning with the oriented collagen fibres within 
the lamellae [7, 8]. The key functions of these lamellae are to retain and restrain the NP. In 
addition, collagen type I provides tensile properties to the AF and enables it to take up and 
distribute the load exerted by this tissue during physiologic joint motions. The collagen 
fibres are cross-linked by a number of molecules bound at their surface which provide 
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optimal mechanical stability. These stabilising molecules include collagen type X, elastin, 
fibromodulins, decorin and lumican among others [9, 10].  
The nucleus pulposus (NP) instead is a gelatinous structure that occupies the central part of 
the IVD and is surrounded by the AF. Cells in the NP are initially notochordal but are 
gradually replaced during childhood by chondrocyte-like cells. Notochordal cells contain 
large vacuoles and prominent cytoskeletal elements as described by in situ studies [11-13]. 
These are distinguished by their biosynthetic profile and unique biologic responses to 
mechanical stimuli. It has been suggested that the NP becomes populated at low densities 
by chondrocyte-like cells that may migrate from the adjacent endplate or inner regions of 
the AF [14]. NP cells are usually located inside lacunae in the surrounding matrix [15].  
A loose and irregular scaffold formed of collagen type II and elastin fibers supports a 
network of proteoglycans (e.g. aggrecan and versican) which provides osmotic properties 
by retaining water molecules in the disc [9]. This is achieved by multiple, negatively 
charged glycosaminoglycan side chains (chondroitin and keratan sulphate) that provide 
resistance to compression and water flow, i.e. swelling pressure [16]. Disc hydration 
represents a key factor in joint loading, muscle activation, and motions of the IVD as it 
generates high magnitudes of fluid and osmotic pressures, interstitial fluid flows, and 
compressive, tensile, and shear stresses and strains within the tissue. The ECM of the NP is 
proteoglycan-rich with aggrecan being one of its main constituents. Aggrecan is comprised 
of approximately 100 chondroitin sulphate chains, each containing polysaccharide chains 
with almost 100 negatively charged groups [17, 18]. These polysaccharides are built from 
some fifty repeat disaccharides that contain one carboxyl and one sulphate negatively 
charged group. The additional 30 keratan sulphate chains are clustered beside the 
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chondroitin sulphate chain [19]. The polysaccharide chains are covalently bound to a 
protein core, which has an N-terminal globular domain that specifically binds hyaluronan, 
i.e. allowing the formation of aggregates [20]. Whereas the C-terminal domain can bind 
fibulins, tenascins and other matrix components which network to other assemblies in the 
disc [21]. A high proportion of free aggrecan, i.e. not bound to hyaluronan, is present in the 
NP when compared to articular cartilage [22]. Apart from the abundant collagen type II, 
other types of collagens are also present in the NP, such as collagen types VI and XI [23]. 
Collagen type VI is particularly important in the IVD, especially in the NP, as it forms a 
beaded filament network that plays a role in organising the closest matrix to the cell i.e. the 
pericellular matrix (PCM). It has been postulated that the function of the PCM might be to 
ensure the biomechanical properties that NP cells have to withstand shear forces [24].   
Hyaline, cartilaginous, avascular and aneural endplates separate the IVD, i.e. NP and AF, 
from the adjacent vertebral bodies. The composition of the endplates includes mainly 
collagen type II, III, V, VI, IX and X, although it may vary with ageing [25]. Integrity of 
this structure is vital for the diffusion of metabolites in and out of the IVD. Its functions are 
to partially absorb the hydrostatic pressure dissipated by the NP under loading as well as to 
prevent it from bulging into the vertebral bodies [26].    
 
1.2.2. IVD physiology 
Due to its enclosed nature, the IVD is the largest avascular tissue in the body. 
Although some capillaries and nerve endings might be present in the most outer layers of 
the AF, it has been suggested that the main source of metabolites are the capillary beds of 
the adjacent vertebral bodies which must traverse the endplate to reach the disc matrix [27, 
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28]. The avascularity of this tissue highlights one of the key features of IVD nutrition and 
metabolism. There is a gradient of oxygen tension and glucose across the IVD which 
reaches the lowest levels in the centre of the IVD. Waste products, such as lactic acid, 
arising from an anaerobic glycolytic metabolism, get diffused in the same manner outwards 
[29]. This diffusion rate conditions the sparse density of IVD cells across the tissue.  
 
 
 
Figure 2. Nutrition in the intervertebral disc. a) Glucose and oxygen concentration decreases gradually 
from the endplate towards the centre of the nucleus pulposus. Lactate concentration displayed the opposite 
course, reaching the highest levels in the inner region of the nucleus pulposus. This profile reflects the nutrient 
and the low pH in the inner region of the disc. b) The sagittal section through the intervertebral disc shows the 
region of the determined concentration (x to y). Picture taken from [30]. 
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1.3. Age-related (degenerative) changes in the IVD 
Disc degeneration is a gradual process graded on the basis of gross morphological 
and histological changes [31-33], which is inevitable as a result of aging [34]. However, the 
extent to which such alterations occur in a given individual at a given time are largely 
variable. First signs of tissue degeneration are already detected in the second decade of life. 
As the IVD ages, there is a progressive destruction of the disc tissue, starting at the NP and 
extending to the AF. Both, ECM and cellular changes are observed, finally leading to a loss 
of the IVD structure and a subsequent replacement by a scar-like tissue [35-39]. 
         We concur with Vernon Roberts that differentiating age-related changes from 
secondary degeneration is very difficult if not impossible [40]. Within this thesis the term 
“age-related changes” is synonymously used with disc degeneration without implying a 
correlation with pain. In a clinical setting, however, a differentiation of painful and painless 
disc alterations is warranted. Extensive  MRI studies have shown that morphological criteria 
have failed to allow for such a distinction [41]. Today, painless discs can be differentiated 
from painful discs by means of provocative discography [42]. However, in this context, 
pathological disc, i.e. pain producing discs are differentiated from painless discs. 
Provocative discography used to diagnose painful disc alterations is still a topic of debate, 
since the mechanism underlying the reproduced pain is not fully understood [43]. 
Furthermore, this diagnostic test is not an objective assessment but instead relies on the 
patients’ response which might be influenced by confounding variables such as psycho-
social and work-related factors [44]. 
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1.3.1. Aetiology of age-related (degenerative) changes of the IVD 
Although the changes and features that occur in the disc during the process of 
degeneration have been well described (sections 1.3.2., 1.3.3., 1.3.4. and 1.3.5.), however, 
the aetiology is still not clear. Degeneration of the IVD is thought to be a multi-factorial 
process involving a mechanical and a genetic predisposition as well as biological factors.  
Mechanical factors such as repetitive manual lifting tasks, vibration exposure, and acute 
overloading have long been implicated in the aetiology of IVD degeneration. In vivo and in 
vitro mechanobiologic studies have clearly demonstrated that mechanical factors can 
influence the biosynthetic activity of disc cells, altering the expression of key extracellular 
matrix molecules [45-47]. 
It was recently demonstrated that additional factors, such as a strong, dominant, genetic 
predisposition as well as biological/nutritional factors, appear to have deeper effects than 
just biomechanics [29, 48]. Genetic predisposition greatly influences degenerative changes. 
In fact, epidemiological studies have described strong family predisposition to disc 
degeneration and herniation [49-53]. Interestingly, studies on identical twins elucidated that 
70% of the explained variance in IVD degeneration can be attributed to genetic inheritance 
rather than to environmental factors [54]. An association of polymorphisms of various sets 
of genes and IVD degeneration has been suggested; these include vitamin D receptor, 
collagen I and IX, cartilage intermediate layer protein (CILP), asporin, aggrecan, MMP-3, 
i.e. mostly involved in ECM homeostasis, as well as cytokines such as IL-1β and IL-6 [55-
70]. However, most of the genetic influence remains to be explained, as genetic 
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predisposition to IVD degeneration implies many genes and it is not possible to distinguish 
between a minority of people with ‘vulnerable’ backs and a majority with ‘normal’ backs. 
Impairments in the precarious supply of nutrients may lead to cell death or degenerative 
changes. These not only severely affect and reduce nutrition, but also increment waste 
products with a further decrease of oxygen tension in the centre of the IVD (Figure 2.). 
Thus, an accumulation in lactic acid drastically decreases the pH of the ECM and 
consequently the synthetic activity of disc cells [29]. Cell culture studies have confirmed 
that disc cells deprived of oxygen have a greatly reduced metabolic rate, and that a 
prolonged shortage of glucose can kill them [71]. Nevertheless, a recent in vivo study 
suggests that the links between impaired metabolite transport and IVD degeneration are not 
straight-forward as one cannot clearly distinguish one condition from another [72]. 
In summary, disc degeneration is a multi-factorial process which is primarily related to an 
interplay between genetic predisposition and nutrition. Additional factors, such as 
mechanical factors, can modulate this interaction causing lesions by abnormal loading or 
mechanical injuries [73, 74]. 
 
1.3.2. Phenotypic and cellular alterations 
 Disc cells actively remodel the ECM, and thereby, are in charge of producing and 
maintaining the ECM that embed them. Therefore, it is sensible to assume that degenerative 
alterations might not only be occurring in the ECM but also in the cells responsible for its 
synthesis and maintenance. For this however, there is only indirect evidence for phenotypic 
changes of disc cells occurring during IVD degeneration. Research in this area is greatly 
hampered by a lack of standard exclusive disc cell reference markers. This cell morphology 
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varies within the IVD itself as discussed in section 1.2.1. Attempts to phenotypically 
characterise disc cells have taken into account the main constituents of the ECM of a 
particular region as well as the environment of the IVD. Disc cells from the NP are referred 
to as ‘chondrocyte-like’cells due to their morphological resemblance to articular cartilage 
chondrocytes. Proposed NP-cell markers include collagen type II, aggrecan, sox-9, HIF-1α, 
MMP-2 and GLUT-1 [75, 76]. Additionally, further microarray analyses of rat coccygeal 
intervertebral discs has shown, via real time RT-PCR, that NP cells have higher levels of 
annexin A3, glypican A3, keratin 19 and pleiotrophin compared to AF cells [77]. 
As degeneration progresses, aggrecan-mRNA expression has been reported to substantially 
decrease[78]. Strikingly, the presence of the phagocytic marker CD68 [79-81] has been 
detected in disc cells from disc tissue with morphological signs of disc degeneration bearing 
no exogenous infiltration. Thus, this finding suggests a phenotypic switch of NP cells to a 
phagocyte-like cell type. In addition, the avascular nature of the disc also favours a 
phenotypic switch rather than the infiltration of phagocytes from outside the IVD. 
Nevertheless, further analyses are required to examine the degenerative changes in the rest 
of the proposed markers.  
In addition to these phenotypical changes, cell clustering due to reactive proliferation is 
observed at an advanced age and advanced stage of degeneration (50-70 years) near 
clefts[33]. 
 
1.3.3. Extracellular matrix (ECM) alterations 
As the disc degenerates, there is a fragmentation and net loss of proteoglycans and 
therefore a loss of water from the nucleus, leading to a reduced osmotic pressure and 
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dehydration in the tissue [78]. This fragmentation affects primarily the proteoglycans 
aggrecan and versican [82]. A reduction in proteoglycans is thought to decrease disc height. 
This feature is particularly marked in the NP, which becomes steadily more fibrous and 
laminated as proteoglycans are slowly replaced by fibrous proteins such as collagens. The 
overall collagen content in the NP remains fairly constant over the years, however that of 
the AF decreases with advancing age [83]. Additionally, qualitative changes involving 
alterations in the distribution and appearance of various collagen types (such as collagen 
type IV and X) and various isoforms in the distinct regions of the IVD have been reported 
[84]. Furthermore, changes affecting the collagen fibres by cross-linking greatly impair 
remodelling or degradation when they become damaged. ‘Non-enzymatic glycation’ results 
in cross-linkings which render the tissue excessively stiff and unable to withstand load; thus 
making it vulnerable to injury. A sign of ‘non-enzymatic glycation’ of proteins is the 
yellow-brown appearance associated with ageing of tissues which has been reported in the 
ageing and degenerated IVD [25] (discussed in section 1.3.5.).  
Apart from proteoglycan and collagen proteins, there are non-collagenous proteins 
occurring abundantly in the IVD. Evidence indicates that some of these non-collagenous 
proteins such as fibronectin undergo age-related changes too [85]. A fundamental 
characteristic in the ageing/degenerative process of the IVD seems to be an imbalance in the 
ECM arising from catabolic and anabolic processes. Degradative enzymes (MMPs and 
ADAMTS [86]) can be produced at levels that overwhelm the production of their inhibitors, 
such as tissue inhibitors of metalloproteinases (TIMPs). For instance, degenerating IVD are 
reported to have increased levels of MMP-3 and ADAMTS-4 (A Disintegrin And 
Metalloproteinase with ThromboSpondin motifs-4) and remarkably low levels of TIMP-1 
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and 3 [33, 87]. Moreover, enhanced focii of tissue proteolysis have been shown by in situ 
zymography to be associated with cleft formation and disc tissue disruption [25]. All these 
remodelling enzymes can be synthesised by IVD cells, however expression may be 
modulated by cytokines, pro-inflammatory mediators and growth factors, such as TNF-α, 
IL-1, IL-8, TGF-β, nerve growth factor (NGF) and prostaglandins, which seem to be 
important players in IVD degeneration and potential pain [85, 86, 88-93]. For example, 
MMP-3 and MMP-13 were reported to be IL-1β dependent. Instead, TGF-β is mostly 
associated with matrix disarrangement through its anabolic properties, even though the 
exact mode of action is yet to be elucidated. This indicates that cytokines and growth 
factors add a modulatory layer to this age-related or degenerative process.  
 
1.3.4. Cellular and ECM modulation by cytokines and growth factors 
Cytokines and growth factors provide a regulatory means as IVD cells have been 
shown to produce and/or respond to such agents (Table 3). In addition, increasing evidence 
indicates that some cytokines and growth factors are responsible for the alterations of the 
disc matrix described in sections 1.3.2 and 1.3.3. [86, 90, 94]. Nevertheless, the expression 
pattern of these factors is unknown to date. Furthermore there is no clear distinction 
whether these factors arise as part of the normal age-related degeneration process or due to 
pathological changes of the disc. 
In the IVD, pro-inflammatory cytokines tend to have mostly a catabolic activity (e.g. TNF-
α and interleukins). Growth factors instead exhibit mostly anabolic effects (e.g. TGF-β) 
[90]. Recent evidence indicates that factors of both classes are induced during age-related 
degeneration, in particular, TNF-α expression has been found to be enhanced in IVD cells 
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with increasing age in non-symptomatic degenerated intervertebral discs [95].  Members of 
the interleukin-1 (IL-1) family were reported to be produced in both non-degenerated and 
degenerated IVD at basal levels; however expression increased with age-related 
(degenerative) changes of the IVD. The expression of these cytokines implies important 
signalling cascades that can be activated such as the induction of MMP synthesis or pro-
inflammatory mediators (e.g. prostaglandins and neurotrophic factors).  
Animal studies using TNF-α support the hypothesis that pro-inflammatory cytokines may 
initiate both a local inflammatory reaction, by rapid diffusion through nuclear and annular 
clefts and tears, as well as inflammation in the peridiscal space, which is very well 
innervated [96] Thus, a link between degenerative processes and the induction of discogenic 
pain is created.  
Besides cytokines, growth factors have also been reported to be synthesised in increasing 
amounts in degenerated IVD as is the case for TGF-β [85]. TGF-β has potent matrix-
inducing activity (anabolic effect) and its expression has been enhanced during 
degeneration implying a rearrangement of the matrix[85]. This finding indicates a putative 
role in matrix disarrangement, including the formation of granulation tissue that is 
characterized by changes in the composition and synthesis of collagen and proteoglycan in 
the ECM, nevertheless the mechanism of TGF-β induction remains unknown.  
Therefore, alterations during degeneration in the expression of cytokines and growth factors 
may disrupt the delicate homeostasis of the tissue that is essential for the maintenance of a 
healthy disc matrix leading to ECM alterations.  
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1.3.5. Oxidative stress 
Oxidative stress modulates the formation of non-enzymatic, post-translational 
glycation in vivo [97, 98] providing a means for the cross-linking of proteins. Non-
enzymatic glycation begins with a reaction between a reducing sugar and a free amino 
group on a protein, lipid, or nucleic acid. Initially, chemically reversible Schiff base and 
Amadori adducts form proportionately to reducing sugar concentration. This initial reaction 
is an amino-carbonyl type condensation of the reducing sugar with a primary amine. The 
rate of formation or degradation of the Amadori products depends on the percentage of 
aldehydic of the sugar; lowest for glucose and highest for ribose and glycoaldehyde [99]. 
Over time, these Amadori products slowly undergo further rearrangements, dehydrations, 
and oxidations resulting in the reversible formation of a family of complex structures that 
are referred to as advanced Maillard reactions including advanced glycation end-products 
(AGEs). Furthermore, the pH plays a fundamental role in the formation of the distinct types 
of advanced Maillard reactions [100, 101]. A common modification is generated by 
oxidative cleavage of Amadori intermediates to form N-(carboxymethyl) lysine (CML) 
structures. Therefore, age-related accumulation of the post-translational protein 
modification N-(carboxymethyl) lysine (CML) is regarded as a marker for oxidative stress 
[102]. Long-lasting proteins such as collagens, elastins and proteoglycans are particularly 
susceptible to AGE deposition, most likely due to the long half lives of these proteins. Thus, 
AGE accumulates due to the normal process of aging and is enhanced in hyperglycaemia. 
Interestingly, age-related changes can be clearly observed in collagen-rich tissues, which 
tend to loose elasticity and become thickened or sclerosed with age [103]. Collagen fibres 
undergo substantial modifications as the fibres become (i) highly thermostable, (ii) have 
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covalently linked fluorophores, (iii) decrease in solubility and (iv) and a reduction in 
digestibility [104-107]. This means of cross-linking through glycated residues has been 
strongly related to abnormal cellular function [108]. The contribution of AGEs to age- or 
hyperglycaemic-related complications might occur through either direct chemical-(covalent 
cross-link formation) or cell surface receptor mediated-pathways. These complications 
include disorders such as osteoarthritis, cataract formation, myocardial dysfunction and 
nephropathy among others [109-112]. A contribution to ageing/degeneration of the IVD 
would therefore be expected through cross-linking, insolubilisation and free-radical-
mediated fragmentation of proteins. CML modifications have been immunolocalised in IVD 
tissues, revealing an age-dependent CML deposition in areas of macroscopic and 
histological disc degeneration [25]. CML and other AGE are ligands can be recognised by a 
number of receptors which include the receptor for advanced glycation end-products 
(RAGE) [25, 113, 114] and the so-called AGE-receptor complex. To date, RAGE is the best 
characterised AGE-receptor that has been reported in chondrocytes from articular cartilage 
to activate NF-κB, presumably through the extracellular-regulated kinase (Erk), Rho, and 
Jak/Stat pathways [115, 116].  
Nevertheless, the origin of oxidants mediating oxidative stress as a prerequisite to induce 
generation of CML-modification in the low oxygen environment as inside the IVD, remains 
unclear. Oxidative enzymes might provide the necessary oxidants to induce oxidative stress. 
A recent study demonstrated that accumulation of CML-modification in matrix proteins is 
impaired in NADPH oxidase-deficient mice [117], implying that in a low oxygen 
environment the oxidants generated by NADPH oxidase may be responsible for the 
generation of CML-modifications [118]. Strikingly, NADPH oxidase is normally produced 
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by cells of myeloid origin, i.e. phagocytic cells, granulocytes, mast cells and dendritic cells 
[119]. As mentioned above, CD68 positive cells have been identified in the NP of 
individuals with histomorphological signs of disc degeneration [39] but with no signs of 
extra-discal infiltration (section 1.3.2.). However, further research is required to find out 
whether CD68 expressing cells also display other phagocytic features such as expression of 
active NADPH oxidase. 
In addition, AGE deposition has been reported to affect  remodelling and destruction of the 
tissue as well as to confer stiffness and brittleness to a tissue [120, 121]. 
 
1.3.6. Consequences of age-related (degenerative) changes 
Inevitably, all these changes lead to increased load on the structures surrounding the 
NP and ultimately the whole spine. Abnormal distribution of forces across the disc results in 
cracking and fissuring of the AF, further decreasing its ability to distribute stresses properly 
during loading causing clefts, tears and granular changes to appear in the ECM. The 
integrity of the EP fails as well with ageing and degeneration. Extensive calcification, 
ossification and cartilage disorganisation may lead to decreased EP permeability; and thus 
compromise the IVD greatly [122, 123]. Additional changes may occur which include 
fissure formation, micro-fractures, horizontal cleft formation and death of chondrocytes. 
Consequently the disrupted IVD can lead to tissue failure, e.g. AF tears, EP damage, or 
facet-joint damage.  
As IVD degeneration proceeds, biomechanical changes in the IVD and the motion segment 
follow. In the early stages of IVD degeneration, the involved motion segment is less stiff 
than in the advanced stages, particularly in flexion-extension and torsion [124, 125]. 
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Vertebral body pathology is also a hallmark of late-stage degeneration and includes 
subchondral sclerosis, end-plate ossification, and osteophyte formation. 
 
 
1.4. Clinical relevance: low back-pain and IVD degeneration 
Low back-pain is common and appears as pain, muscle tension, or stiffness localised 
below the costal margin and above the inferior gluteal folds, with or without leg pain 
(sciatica) [126]. Low back-pain is the leading cause of  restricted activity and bed rest in the 
US working population and it is the second leading symptom (after that of common cold) 
that prompts visits to physicians [127, 128]. Moreover approximately 85% of the population 
in western industrialised societies experience low back-pain at least once during their lives, 
underlying its dramatic impact on society [129-131]. Low back-pain has a strong tendency 
to become chronic, reaching 36% for a 12-month incidence [132]. Chronic low back-pain 
and its treatment is a growing socio-economic problem in western industrial countries. 
Waddell has documented a dramatic increase in low back-pain disability in Great Britain 
that may be representative of Western societies [128].  
Low back-pain can be differentiated into specific and non-specific disorders. Specific back- 
pain is related to a clear morphological correlate while non-specific back-pain is not. In 
about 85 to 90% of the individuals, no clear cause of back-pain can be identified despite 
intensive diagnostic tests. Specific spinal syndromes leading to leg pain are caused by disc 
herniation (radiculopathy) or a narrow spinal canal (spinal claudication). Among the 
putative causes of specific back-pain are symptomatic facet joint osteoarthritis, segmental 
instability and painful disc degeneration. The dramatic changes that occur in the 
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intervertebral disc with age (Fig. 1) make many clinicians and researchers believe that the 
disc is a predominant source of back-pain. The so-called discogenic pain syndrome is a 
result of painful disc degeneration. Epidemiological studies using MRI have shown that 
morphological alterations in the intervertebral disc do not allow differentiation of 
symptomatic from asymptomatic individuals since almost all morphological alterations can 
occur in both groups [133]. It is therefore assumed that biochemical alterations are the 
decisive factor why a degenerated disc may become painful. Such biochemical mechanisms 
that link morphological alterations in the ECM matrix, especially in the NP, during 
degeneration with the induction of pain are still unknown. It has been demonstrated that 
resident disc cells undergo phenotypical alterations (section 1.3.2.) due to the stress 
imposed on them by the progressively worsening environmental conditions inside the 
degenerating disc. These alterations lead to altered gene expression patterns of the disc 
cells, and may induce the expression of mediators that contribute to or cause pain inducing 
signalling mechanisms. Among potential candidates for such mediators are the pro-
inflammatory cytokines. Olmarker and co-workers showed that NP-induced nerve root 
injury during herniation can be mimicked by a local application of TNF-α to the nerve roots 
[134-136]. In a degenerated, non-herniated disc it is conceivable that TNF-α produced by 
NP cells can diffuse out of the disc through clefts and tears. In the periphery, TNF-α might 
directly or indirectly (via further cytokines) irritate the nerve endings in the outermost part 
of the AF or the nerve roots in the epidural space. Besides TNF-α, disc cells have been 
shown to be able to synthesize several additional pro-inflammatory cytokines including IL-
1α/β, IL-6, IL-8, and GM-CSF [90, 137]. These findings support the idea that pro-
inflammatory cytokines produced by resident disc cells might be involved in the induction 
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of low back-pain. Despite extensive evidence that pro-inflammatory reactions play a 
significant role, the mechanisms linking morphological changes during disc degeneration 
with pain induction responsible for discogenic pain are still not well explored. Furthermore, 
NF-κB (described in detail in section 2. and 3.) is known to play a central role in the 
regulation of pro-inflammatory cytokines, adhesion molecules, chemokines, growth factors 
and inducible enzymes such as cyclooxygenase 2 (COX2) and inducible nitric oxide 
synthase (iNOS) (reviewed in [138]). Therefore, the activation of NF-κB by various stimuli 
during degeneration might be the starting point for a pro-inflammatory signaling cascade in 
the intervertebral disc and may be the decisive factor determining whether an intervertebral 
disc becomes painful and results in the clinical syndrome of discogenic back-pain.  
 
1.5. Experimental models 
1.5.1. In vitro models 
In vitro systems include cell culture (e.g. monolayer and three-dimensional) 
systems, tissue culture, and organ culture with end plates. Each culture system has its own 
advantages and disadvantages for specific experiments. Furthermore, the handling and 
culture of IVD cells has been proved to be complicated. Although it is possible to expand 
IVD cells in routine monolayer cultures, the cells tend to differentiate and therefore lose 
their native phenotype [139]. Three-dimensional culture systems of isolated IVD cells helps 
to circumvent these problems by allowing the maintenance of disc cell morphology, proper 
cell-cell interactions and providing suitable environmental signals [140]. Several three 
dimensional-culture systems have been used throughout the literature for IVD cells such as 
alginate beads, collagen matrices, agarose and fibrin gels, pellets and biocompatible 
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polymer scaffolds [141-147]. Except for the pellet system which consists of cell aggregates, 
the other three dimensional-culture systems need to introduce foreign matter to the isolated 
disc cells, thus alterations of the direct cellular microenvironment might occur; in fact, IVD 
cells behave differently in each culture system [148]. Considerations in regard to culture 
supplements such as ascorbic acid and serum may also influence the outcome in an 
experiment.  
 Tissue or organ culture might be more applicable in in vivo than in cell culture-based 
models. The main drawback is to keep the cells viable despite changes in the diffusion rate 
of metabolites, oxygen and substances across the tissue as well as the poor reproducibility 
of these culture systems. 
Besides the in vitro model, the source of IVD cells for the study of human pathogenesis of 
IVD degeneration should also be carefully evaluated. AF and NP cells have diverse 
biomechanical as well as biosynthetic activities and species specificity, as well as the age 
and severity of degeneration of the donor IVD and cells can greatly affect the outcome of an 
experiment.  
    
1.5.2. In vivo models 
In addition to being able to model human pathologic processes, an animal model 
must be ethical, controllable, reproducible, and cost-effective. In vivo studies are hampered 
by the invasiveness of the procedures and concerns surrounding the care and use of animals. 
A variety of in vivo animal models for IVD degeneration are described in  literature, each of 
with has its own advantages and disadvantages [149-151]. Small animal models that include 
rats or rabbits are relatively inexpensive, but the small spinal structure, cell maturity and 
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cell type may not be ideal for biomechanical or biological experiments. Larger animal 
models, although more expensive, resemble the mature human IVD from the point of view 
of the cell biology and biochemistry. The content of notochordal cells and chondrocytes and 
the transition times from notochordal to chondrocytic cells in the NP vary between species 
[152]. Generally, the higher the animal species is in the phylogenic tree, the slower the 
natural process of degeneration. 
Naturally occurring IVD degeneration aging models include rats, chondrodystrophoid dogs 
and primates [153-158], specifically the sand rat has been reported to have very similar 
degenerative disc changes to humans, occurring spontaneuously and at a young age [159-
161].  
On the one hand, naturally occurring models have advantages over injury models with 
regard to the biological changes with ageing and degeneration over time. The main 
disadvantage of naturally degenerating animal models however is the unknown rate and 
percentage of degeneration in a group. On the other hand, artificially induced degenerative 
changes are invaluable in creating clinically applicable and reproducible animal models of 
degeneration. These injuries tend to lead to rather quick degenerative changes in the IVD 
when compared to naturally-occurring models. These include postural change, tail 
suspension, axial loading, knife stab or puncture of the AF-totally or superficially- resection 
of the lamina and facet joint, EP injury or cementing of discs adjacent to a fusion and 
chemonucleolysis among others [162-165]. 
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2. Nuclear Factor-KappaB (NF-κB)  
NF-κB was initially identified in 1986 as an inducible nuclear factor bound to the 
immunoglobulin κ light chain enhancer in B-cells [166]. Additional studies however 
revealed that NF-κB is expressed in almost all cell types [167]. NF-κB is induced by a vast 
number of very different stimuli ranging from biological substances such as inflammatory 
cytokines, chemokines, bacterial lipopolysaccharides (LPS) or RNA viruses to phorbol 
esters and cytotoxic stimuli such as UV light and ionising radiation [168]. Upon induction, 
NF-κB activates a variety of target genes and thus regulates many diverse biological 
processes such as the innate and acquired immunity, cell proliferation or apoptosis [168]. 
Aberrant activation of NF-κB may result in a chronic or exacerbated inflammation 
associated with many diseases such as rheumatoid arthritis, asthma, atherosclerosis, cancer 
and Alzheimer’s disease [169-173]. This highlights the importance of a tight and 
coordinated regulation of NF-κB.  
 
2.1. The mammalian NF-κB family members 
The NF-κB family of inducible transcription factors in mammals has 5 members, 
p65(RelA), RelB, c-Rel, p105/p50and p100/p52 encoded  by RELA, RELB, REL, NF-κB1  
and NF-κB2, respectively [174, 175] (Figure 3).  
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Figure 3. The NF-κB, IκB, and IKK protein families. The number of amino acids in each human protein is 
indicated on the right. Post-translational modifications that influence IKK activityor transcriptional activation 
are indicated with P for phosphorylation, U for ubiquitination, or Ac for acetylation. Inhibitory events and 
phosphorylation and ubiquitination sites on p100, p105, and IκB proteins that mediate proteasomal 
degradation are indicated with red Ps and Us, respectively. RHD, Rel Homology Domain; TAD, 
transactivation domain; LZ, leucine zipper domain; GRR, glycine rich region; HLH, helix-loop-helix domain; 
Z, zinc finger domain; CC1/2, coiled-coil domains; NBD, NEMO-binding domain; MOD/UBD, minimal 
oligomerisation domain and ubiquitin-binding domain; and DD, death domain. Figure taken from [176]. 
 
 
All family members share the Rel Homology Domain (RHD), which is located at the N-
terminus and is approximately 300 amino acids long. The RHD mediates DNA binding, 
dimmerisation, nuclear localisation and interaction with the inhibitory IκB proteins [177]. 
p65(RelA), RelB and c-Rel are the only family members containing a C-terminal 
transcription activation domain (TAD), which enables gene activation [178]. In contrast, 
p50 and p52 contain no TAD but a C-terminal ankyrin repeat domain. p50 and p52 are 
proteolytically processed from the precursor proteins p105 and p100, respectively [179].  
Diverse combinations of NF-κB subunits lead to the formation of homo- and heterodimmers 
which have different affinities to distinct DNA binding sequences, the κB sites, and regulate 
differentially specific genes [180]. The best studied heterodimmer is p65(RelA)/p50. 
 
2.2. NF-κB signalling pathways 
 The simplified view of NF-κB regulation involves the retaining of NF-κB in an 
inactive form in the cytoplasm by IκB proteins; thereby transcriptionally inactivating NF-
κB. In response to extracellular stimuli, IκB is phosphorylated by activated IKK, which 
leads to ubiquitination of IκB by ubiquitin ligases and its degradation by the 26S 
proteasome, releasing NF-κB dimmers [177]. The MDa IκB kinase (IKK) complex is 
composed of the kinases IKK1/IKKα, IKK2/IKKβ  and the regulatory domain 
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NEMO/IKKγ (NF-κB essential modulator) which has no intrinsic kinase activity [181-184]. 
Induction of NF-κB leads to subsequent nuclear translocation of NF-κB dimmers, which 
will bind to consensus sequences to activate the transcription of target genes. The 
termination of the response involves a negative feedback due to activated NF-κB dependent 
IκB expression or ubiquitin-mediated proteosomal degradation of NF-κB [185, 186]. IκB 
and IKK proteins are central players in the regulation of NF-κB activation. Nevertheless, 
the established model in which certain IκB family members retain NF-κB dimmers in the 
cytoplasm, preventing nuclear translocation and subsequent DNA binding is more complex. 
Despite steady-state localisation that appears almost exclusively cytosolic, there seems to be 
a constant shuttling between the nucleus and the cytoplasm of the NF-κB/IκB complex 
[187]. IκB proteins (IκB α, β, ε) contain at the C-terminus protein interaction motifs, 
referred to as ankyrin repeats, which mediate the interaction with NF-κB [188, 189]. The 
crystal structure of the NF-κB/IκBα has revealed that IκBα masks only the nuclear 
localisation sequence (NLS) of p65(RelA), whereas the NLS of p50 remains exposed. The 
exposed NLS of p50 coupled with nuclear export sequences in IκBα and p65(RelA) leads 
to this dynamic shuttling between the two compartments. 
Additionally, p105 and p100, i.e. the unprocessed forms of p50 and p52, have an IκB-like 
function due to their ability to retain NF-κB dimmers in the cytoplasm via their ankyrin 
repeats [190]. There are also inducibly expressed IκB family members, Bcl-3 and IκBζ, 
which function quite differently in the regulation of NF-κB [191, 192]. 
Upon stimulation, two different types of NF-κB signalling pathways can be activated, the 
canonical (classical) or the non-canonical (alternative) pathway (Figure 4) [193-195].  
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Figure 4. Canonical and non-canonical NF-κB activation pathway. a) Canonical/classical activation ends 
with the release of the p65/p50 heterodimer into the nucleus; b) Non-canonical/alternative pathway is slower 
and generates p52/RelB heterodimer. Picture taken from [195]. 
 
 
The canonical pathway is activated by various stimuli such as pathogen-associated 
molecular patterns (PAMPs) and pro-inflammatory cytokines (IL-1, TNF-α) that act 
through different receptors such as TNF receptor (TNFR) or Toll-like receptor 
superfamilies  [196]. The canonical pathway is regulated by IKKβ in a NEMO-dependent 
manner, catalising the phosphorylation of IκBs (at serine residues 32 and 36 in IκBα), 
lysine ubiquitination (at lysine residues 21 and 22 in IκBα) and degradation by 26S 
proteosome [177]. This process results in DNA binding and subsequent activation of gene 
transcription by NF-κB dimmers predominantly formed by p65(RelA), p50 or c-Rel [187]. 
The canonical pathway mainly activates genes involved in the regulation of the immune 
system such as cytokines, chemokines, adhesion molecules, enzymes that produce 
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secondary inflammatory mediators and inhibitors of apoptosis [197]. Knockout mice for 
IKKβ are associated with an enhanced susceptibility to infections [198, 199]. 
The non-canonical pathway however is triggered by a subset of stimuli such as BAFF (B-
cell activating factor), CD40 ligand or lymphotoxin β (LTβ) in fully developed T and B 
cells i.e. the adaptive immunity [200-203]. Activation of the non-canonical pathway leads to 
a sustained NF-κB response, involving IKKα activation (independent of IKKβ and 
NEMO). This leads to the phosphorylation of two C-terminal amino acid residues of p100 
and the processing to p52, thereby liberating p52 containing dimmers and leading to nuclear 
translocation of p52/RelB heterodimmers [199]. Phosphorylation of the precursor form 
p100/p52 is essential for the processing of p100 to p52 which is also dependent on 
ubiquitination of the inhibitory C-terminal half of p100 and proteosomal degradation [179]. 
The non-canonical pathway seems to play a role in the development and maintenance of 
secondary lymphoid organs. Knockout mice for Nfkb2, RelB, IKKα, c-Rel and Nfkb1 have 
an impaired B cell population and proliferation, in the germinal centres of the spleen [199, 
204-206]. 
Alternative pathways that activate NF-κB have also been described, e.g. by DNA damaging 
agents (UV irradiation or doxorubicin) [207, 208]. 
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3. Regulation of NF-κB 
The inducible regulation of gene expression is a central element of normal 
physiology and is the key for a multicellular organism to adapt to environmental, 
mechanical, chemical, and pathogenic stresses. The diversity of biological roles fulfilled by 
NF-κB raises several questions about how a limited set of signal transduction molecules 
regulates signalling to NF-κB in all pathways and, conversely, how discrete inputs create 
transcriptional responses tailored to specific type of cells, tissues and organs with the same 
set of regulators. As NF-κB activation can occur by numerous stimuli, triggering 
transcriptional activation of approximately 500 different genes, a tight regulation of the NF-
κB machinery is required [168]. This is achieved by additional regulating levels: a) at the 
cellular level, e.g. differential induction of NF-κB subunits and IκB proteins, recruitment of 
co-regulators, post translational modifications of NF-κB/IκB/IKK and epigenetics or b) at 
the tissue or organ level, e.g. NF-κB can be regulated by receptor/signalling cascades. All 
of these layers of regulation are described in the following sections. 
 
3.1. Degradation of specific IκB proteins 
 Degradation of specific IκB proteins is due to certain signals which also determine  
the duration of the NF-κB induction [209]. For instance, IκBα degradation is involved in a 
quick and transient response, whereas IκBβ and IκBε degradation leads to a slow and 
sustained response [210]. Moreover, distinct IκB proteins associate with a higher affinity 
with certain NF-κB dimmers (e.g. p65(RelA)/c-Rel with IκBε [211]).  
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3.2. NF-κB dimmers and binding to κB sites 
 The dimmerisation of the five NF-κB family members in mammals, which results in 
homo and heterodimmers, leads to a broad spectrum of possibilities for gene targeting and 
activation. Dimmerisation is a prerequisite for DNA binding. There are 12 activating and 3 
repressing dimmers that recognise κB sites [178]. An important feature determining cell and 
tissue specificity is the fact that the pattern of dimmer formation in different cell types is 
limited to the specific expression pattern of the NF-κB subunits in each cell type. 
The formation of different dimmers and consequently their specific functions in diverse cell 
types has been described throughout the literature. Homodimmers formed by either p50 or 
p52 bind to the promoter and repress transcription in unstimulated cells. In contrast, 
heterodimmerisation of p50 or p52 with a TAD-containing member, will lead to the 
formation of transcription competent complexes [212].  The heterodimmer formed by 
p65(RelA) and p50, i.e. p65/p50, has a high affinity to κB sites and is very abundant in 
mammalian cells. As, for instance, in fibroblasts where the majority of TNF-α regulated 
NF-κB genes are transcribed by p65(RelA)/p50 heterodimmers [213]. Additional examples 
of cell type or tissue specific NF-κB dimmer patterns include c-Rel and RelB. c-Rel is 
encountered in haematopoietic and lymphocyte cells. c-Rel knockout mice  have been 
shown to exhibit adaptive immunity as well as innate immune defects in macrophages 
[214]. As for RelB, which is mainly expressed in lymph nodes, Peyer’s patches and certain 
parts of the thymus, knockout mice have shown not only adaptive immunity but innate 
immune defects in dendritic cells [215]. This observation emphasises the vast effects of a 
specific dimmer which goes beyond affecting only a part of a process, in this case, adaptive 
versus innate immunity.  
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Another aspect which influences tissue specificity is the formation of specific dimmers at a 
certain developmental stage. In the case of monocytes and monocyte-derived-macrophages, 
p50 homodimmers were detected in both unstimulated cells [216]. However, upon LPS 
stimulation p65(RelA)/p50 and RelB/p50 were only unregulated in macrophages and not in 
other monocyte-derived cell type.  
NF-κB dimmers bind DNA mainly through 10bp long-κB sites with the loose consensus 
sequence 5’-GGGRNWYYCC-3’ (R=purine, W=adenine or thymine, N=any base, 
Y=pyrimidine) [217, 218]. The κB sites in many promoters are conserved through evolution 
highlighting the importance of the sequence function for selectivity. The stringency of the 
dimmer binding to κB sequences and the degree of involvement of the dimmer recruitment 
is yet not completely clarified. 
 κB sites are classified according to the bound dimmers: first, class I, for p65(RelA)/p50 
and p50/p50 dimmers; and second, class II, where p65(RelA)/p65(RelA) and p65(RelA)/c-
Rel bind [219]. Additional evidence highlights the importance of the κB sequence to  
influence the recruitment of cofactor interacting with a specific dimmer [220, 221]. 
Together, the degenerate nature of the κB site sequence implies a great sequence variability 
leading to different binding preferences of the NF-κB dimmers and confers a great 
polyvalence for the subsequent response [222].  
 
3.3. Transcriptional co-regulators of NF-κB 
NF-κB dimmers bind to κB sites within the promoters of target genes and regulate 
transcription through the recruitment of co-regulators, which include co-activators and co-
repressors. Thus, a tight coordination arises between transcriptional co-regulators and NF-
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κB. Cell or tissue specificity may be further achieved by expressing co-regulators only in a 
subset of cells. TAFII105, for example, is a cell-type specific, transcriptional co-regulator 
confined to B-cell [223].  
Co-activators are classified into three groups: a) those modifying histones that regulate 
DNA access, b) members of the mediator complex which mediate the interaction with the 
general transcription factor apparatus and RNA polymerase II and c) chromatin remodelling 
proteins, i.e. with DNA-unwinding abilities [224].  
Co-activators influencing NF-κB activity include histone acetyltransferases (HATs) like 
p300/CBP, P/CAF, SRC-1, protein arginine methyltransferase CARM-1/PRMT4, 
poly(ADP-ribose)-polymerase-1 (PARP-1) and RNA helicase A [212, 225-232]. Co-
repressors include for instance histone deacetylases (HDACs) and MYBBP1a [233-235]. 
HDACs have been reported to form a complex with the p50 homodimmer bound to certain 
κB-sequences and thereby downregulate gene expression [236]. Acetylation by HATs and 
deacetylation by HDACs can occur on histone and non-histone proteins. MYBBP1a  
instead, competes with p300 for the transcriptional activation domain (TAD) of p65/RelA 
[235]. In fact, expression levels of MYBBP1a depend on the cell type.   
Proteins that are usually co-activators can, under certain circumstances, also act as co-
repressors and vice versa, as it was it has been described for HDACs or p300/CBP [237-
238]. Bladder and breast cancer cells treated with various HDACs inhibitors have revealed 
a comparable number of up- and downregulated genes implying that HDAC activity may 
not always involve transcriptional repression [237]. p300/CBP can activate reporter gene 
expression by binding to the transcription activation domain of p65(RelA) [226-227]. 
However, p300 can also repress transcription in vitro using defined specific conditions with 
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chromatinised templates [238]. Two independent co-regulators may be recruited to a same 
promoter due to two diverse stimuli. Brg1 or P-TEFb can interact with p65(RelA) upon 
stimulation with IL-1β or TNF-α, respectively, leading to their simultaneous recruitment to 
the IL-8 promoter [239, 240].  
In addition to traditional co-activator and co-repressor complexes, there is a growing list of 
proteins that interact with NF-κB dimmers and affect its DNA binding and subsequent NF-
κB-dependent transcription [241]. A recent addition is the ribosomal protein S3 (RPS3), 
which seems to be required for the binding of NF-κB at specific κB sites upon lymphocyte-
activating stimuli involved in rapid cellular activation responses [242]. 
 
3.4. Post-translational modifications of NF-κB 
Transcription of target genes is further regulated through post-translational 
modifications of the TAD or RHD of NF-κB that affect the ability of NF-κB dimmers to 
interact with other proteins. Post-translational modifications of the various NF-κB subunits, 
IκB and IKK proteins described to date, are shown in Figure 3.  
The stimulus-dependent phosphorylation of p65(RelA) by protein kinase A (PKA) was the 
first evidence that NF-κB is subject to post-translational modifications [243]. To date 
described post-translational modifications of NF-κB include phosphorylation, acetylation, 
ubiquitination, prolyl-isommerisation and tyrosine nitration [212, 244-246].  
There are various phosphor-acceptor sites in the NF-κB subunits. The best characterised are 
those on p65(RelA) occuring in the RHD (serine residues 276 and 311) and in the TAD 
(serine residues 529 and 536) [182-185] (Figure 3). Phosphorylation events appear to be 
critical for the induction of p65(RelA) and to facilitate p300/CBP binding [247]. Serine 276 
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mapped in the RHD has been found to be phosphorylated by kinase A (PKA) and mitogen-
and stress-activated kinase (MSK1 and MSK2) which are activated by LPS or TNF-α, 
respectively [236, 248]. MSK1 and MSK2 share substrate specificity with PKA. However, 
phosphorylation itself takes place in different cellular compartments, specifically in the 
cytoplasm for PKA or at the IL-6 promoter, i.e. nucleus, for MSK1.  
Protein acetylation is the most abundant protein post-modification in eukaryotes [249]. 
Acetylation on lysine residues in contrast is less common than in other amino acid residues 
but has been recently reported for p50 and p65(RelA). The reaction catalised by HATs 
transfers an acetyl group from the acetyl coenzyme A (acetyl-coA) onto the amino group of 
a lysine residue [250]. The reaction can be reversed by HDACs, and provides a dynamic 
response to signalling events. Acetylation of p65(RelA), most likely by p300/CBP and 
associated HATs, occurs in the nucleus and is associated with an altered transcription [251]. 
p50 can also be acetylated leading to an increased DNA binding affinity of p50/p50 and 
p65(RelA)/p50 dimmers [252]. Direct acetylation on p65(RelA) both in vitro and in vivo 
has been reported to affect different cellular processes [233, 253, 254]. Acetylation of lysine 
122/123 in the RHD of p65(RelA) reduced its DNA binding activity but not its association 
with IκBα. Thus, acetylation of these lysine residues shortens the length of NF-κB 
induction. Instead, lysine 221 acetylation increases the affinity for DNA binding and 
prevents IκBα association, thereby implying a prolonged NF-κB response. Acetylation of 
lysine 310 has been shown to enhance transcriptional activity without altering the binding to 
DNA or IκB [247]. Furthermore, p65(RelA) can be acetylated by p300/CBP at lysine 
residues 314/315 which were reported to repress or activate different genes [255]. Thus, 
acetylation can contribute to the specificity of the NF-κB response.  
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Another post-translational modification identified in recent years still under debate, include 
tyrosine nitration of p65(RelA). Nitration at tyrosine residues 66 and 152, results in 
p65(RelA) export and rapid inactivation of NF-κB [246]. 
 
3.5. Epigenetic regulation of NF-κB 
The human body is composed of many different tissues and cells, most of which are 
terminally differentiated and perform a specific function [256]. These specialised cells can 
be potentially replaced by a limited pool of stem cells that have the ability to replicate and 
differentiate into a number of specific cell types [257]. Differentiated cells have a specific 
phenotype and physiology, leading to a specific pattern of gene expression that  arises 
during differentiation by genomic imprinting including DNA methylation patterns, 
chromatin remodelling events, heterochromatin formation and formation of special nuclear 
structures [256]. Therefore, it is important to determine the mechanisms by which NF-κB 
dimmers interface with chromatin in gene expression.  
DNA is packaged into a highly organized and dynamic protein-DNA-complex named 
chromatin. The nucleosome is the basic subunit of chromatin and is formed by an octamer 
of four core histones; an H3/H4 tetramer, and two H2A/H2B dimmers, surrounded by 
146 bp of DNA [258, 259]. The nucleosome prevents the access of transcription factors and 
RNA polymerase II them from performing recognition sequences on DNA, therefore 
imposing a barrier to the initiation of transcription. A major mechanism of transcription 
regulation is the alteration of the chromatin structure surrounding genes and their regulatory 
elements. The chromatin structure confers cell type specific positioning of a chromosome 
within the nucleus, which can affect its heterochromatin status [260].  
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Specific cell localisation of genes within chromatin territories determines the potential 
activity of these genes. For instance, genes located on the outside the chromatin territory are 
more active than those within the territory or at the nuclear periphery [256]. This allows the 
repression of a vast number of genes, whose protein products are not necessary in a 
specifically differentiated cell. NF-κB-dependent genes are divided into genes containing: 
a) constitutively and immediately accessible promoters that do not require chromatin 
modification and b) late accessible promoters that are dependent on stimulus-induced 
chromatin modification [261]. The local chromatin structure varies from one cell type to 
another as the cells possess different patterns of histone modifications and positioned 
nucleosomes in a certain region of specific genes. A well documented example of the direct 
regulation of local chromatin to the transcriptional potential of p65(RelA) is the chromatin 
surrounding the E-selectin promoter [262]. E-selectin is an adhesion protein expressed only 
in endothelial cells and is involved in the binding of leukocytes at sites of infection and 
inflammation. Expression of E-selectin was reported to be regulated by NF-κB and pro-
inflammatory cytokines. When the proximal promoter of E-selectin was used in reporter 
assays, it was activated in non-endothelial cells, which implies that the endogenous E-
selectin expression is regulated by its endogenous status.  
Moreover, the pattern of heterochromatin, i.e. the form of chromatin which is highly 
condensed throughout the cell cycle, varies within an organism among its cell types and 
allows the repression of genes that are not necessary for the specialised function of a 
differentiated cell [263]. In contrast to differentiated cells with a specific pattern of 
heterochromatin, stem cells have little heterochromatin, thereby allowing multiple potential 
differentiation pathways [260]. Cell type specific heterochromatin and chromatin structure 
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are likely to have a large role in the regulation of NF-κB dependent transcription but further 
research is required. 
 
3.6. Receptors/Signalling cascades 
 A broad spectrum of stimuli ranging from endogenous, exogenous, physical and 
chemical stresses lead to the activation of NF-κB. Cell and tissue specificity is greatly 
dependent on the cell surface receptors and signal transduction molecules that are specific 
to a determined type of cell or tissue. An example of cell specificity through cell surface 
receptors are CD14 and TLR4, which are exclusively found in myeloid cells. Briefly, LPS 
binds to CD14, activating Toll-like receptor-4 (TLR-4) and downstream signalling pathway 
as well as transcriptional factors that regulate the expression of many different 
inflammatory cytokines [264]. Therefore, cell receptor specificity of CD14 and TLR-4 
implies that LPS can activate NF-κB only in these cells.  
The recognition of stimuli is achieved by receptor-ligand. TLRs is a family of proteins 
shared between different stimuli in the canonical pathway. However, depending on the 
specific ligand, a particular TLR is activated. This enables the innate immunity to deal with 
a wide diversity of PAMPs. TLR2 recognises a spectrum of microbial products such as 
peptidoglycans and lipoprotein, produced by Gram positive bacteria. However, TLR3, 
TLR4, TLR5 and TLR9 recognise other PAMPs such as double stranded RNA produced by 
viruses, LPS from Gram negative bacteria, bacterial flagelling, and non-methylated 
bacterial DNA, respectively [265-268]. Ligand binding to all of these TLRs leads to the 
activation of NF-κB and subsequent induction of target genes [269].  
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The TNF receptor-associated factor (TRAF) family of proteins constitute key intermediates 
in both, the canonical and non-canonical NF-κB signalling pathways [270-272]. Different 
TRAF family members are recruited intracellularly upon distinct stimulation. In the 
canonical pathway, distinct TRAFs are recruited depending on the activated receptor. 
TRAF2 and TRAF5 are both required for NF-κB activation through TNFR1, TRADD, and 
TNF-α [273-275]. Conversely, in Toll/IL-1 signalling TRAF6 is recruited by the receptor 
complex and is necessary for MyD88-dependent activation by IL-1 and ligands of TLR4 
[184, 276]. In the non-canonical pathway, TRAF3 is normally recruited by the receptor 
upon stimulation,  and undergoes signal-dependent degradation leading to NIK 
accumulation and activation of NF-κB gene expression [277].  
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4. Aim of the thesis 
Age-related (degenerative) changes of the IVD occur on the extracellular matrix and 
on the phenotype of IVD cells. A key factor for these alterations is a compromised disc 
nutrition which occurs with ageing. Moreover, oxidative stress in the IVD leads to the 
appearance of advanced glycation end products (AGEs). Cellular stress can also lead to the 
formation of highly damaging oxidants (e.g. peroxynitrite) which induce tyrosine nitration. 
These alterations can potentially lead to the activation of NF-κB, a transcription factor that 
regulates the expression of a large variety of genes involved in pro-inflammatory responses. 
Pro-inflammatory mechanisms are thought to play a decisive role in the degenerative 
changes of the IVD and possibly link to the appearance of subsequent pain.  
The aim of this thesis was therefore to investigate the underlying signalling cascade, 
casually linking age-related cellular- and extracellular- post-translational alterations to a 
NF-κB-dependent pro-inflammatory pathway. As a response, the released cytokines may 
either directly or indirectly (e.g. via neurothrophic factors) cause nociception at the outer 
annular disc fibres resulting in discogenic back-pain.  
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5. Research articles 
 
5.1. Role of N-(carboxymethyl) lysine modifications in NF-κB translocation and   
MMP-13 gene expression in bovine nucleus pulposus cells. 
Submitted manuscript 
 
5.2. Peroxynitrite induces gene expression in human intervertebral disc cells. 
Submitted manuscript 
 
 
 
 
 
My contribution to both papers was the conception and performance of all the experiment 
and the write up of the manuscripts. 
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Study design: Bovine nucleus pulposus (NP) cells were cultivated in monolayers and 
stimulated with advanced glycation end products (AGE) or N-(carboxymethyl) lysine 
(CML). AGE receptor expression, NF-κB activation, MMP13 and cytokine profiling were 
analysed.  
Objective: To determine the effect of AGE/CML on NP cells. 
Summary of Background Data: Age–related accumulation of AGE as CML has been 
reported in human intervertebral discs (IVD). AGE/CML can be recognised by various 
receptors; ligand binding to the receptor can potentially lead to activation of NF-κB with 
induction of a pro-inflammatory cascade as well as influencing tissue remodelling by 
activation of proteinases.    
Methods: NP cells with pericellular matrix (“chondrons”) were isolated from bovine 
coccygeal IVD by partial digestion to avoid disruption of the cell. NP cells were grown in 
monolayers and expanded in media DMEM/F12 containing low glucose and serum levels to 
resemble the conditions encountered in a normal intervertebral disc (IVD). AGE or CML 
modified BSA was used to stimulate NP cells. The AGE receptor expression and levels of 
the pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) were monitored by RT-PCR or 
quantitative RT-PCR, respectively. NF-κB/p65 subunit translocation into the nucleus and 
MMP13 expression were analysed by immunoblotting.  
Results: Neither AGE nor CML-BSA induced changes in the gene expression of cytokines 
nor in the AGE-receptors analysed in this study. However, NF-κB/p65 subunit was 
translocated into the nucleus of bovine NP cells on stimulation, indicating that AGE/CML 
activated NF-κB. Furthermore, CML-BSA increased protein levels of the MMP-13 pro-
form.  
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Conclusion: Our data suggest that the expression of the examined AGE receptors were not 
affected by its ligands AGE/CML. However, AGE/CML did activate NF-κB and the NF-
κB-dependent proteinase MMP-13, implying that the accumulation of AGE in the matrix 
affected tissue remodelling and/or disruption. 
 
 
Key words: Advanced glycation end products (AGE), N-(carboxymethyl)lysine (CML), 
NF-κB, MMP-13, disc degeneration, low-back pain, discogenic pain, intervertebral disc 
 
Key points:  
• AGE and CML i.e. non-enzymatic glycoxidation protein modificatons lead to NF-
κB activation in a bovine chondron culture model.  
• No significant effect of AGE or CML on the pro-inflammatory cytokines: IL-6, IL-
1β and TNF-α.  
• CML modulates MMP-13 expression indicating a putative role in disc matrix 
remodelling.  
 
Mini Abstract/Precis: Age–related accumulation of advanced glycation end products 
(AGE), i.e. N-(carboxymethyl)lysine (CML), have been reported in human intervertebral 
discs (IVD). The bovine chondron model has enabled the study of the effects in vitro of 
AGE/CML showing an NF-κB dependent pathway and modulating MMP-13 expression.  
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Introduction     
Disc degeneration is an age-related process which can start as early as the second 
decade of life 1. The compromised disc nutrition at the end of the second decade of life 
appears to be key in initiating disc degeneration 2. Physiological alterations of the 
intervertebral disc (IVD) involve a limited supply of oxygen and nutrients, i.e. glucose, as 
well as an acidic pH due to lactate accumulation 3-7. However, the molecular pathways 
connecting the changes in the environment of the IVD cells to the matrix alterations and 
possible breakdown remain widely unknown. These alterations include loss of 
proteoglycans from the nucleus pulposus, degradation of matrix components by locally 
expressed proteinases and a reduction of the number of disc cells (reviewed in 8,9). Matrix 
proteins present in the extracellular matrix (ECM) of the IVD can also be modified by post-
translational modification. Post translational non-enzymatic glycation, known as Maillard 
reaction, results in the formation of various species of advanced glycation end products 
(AGE) such as N-(carboxymethyl) lysine (CML), N-(carboxyethyl) lysine (CEL) and 
pentosidine 10-13.  CML is one of the best-characterised AGE-species and is considered a 
biomarker for enhanced or accumulated oxidative stress in the respective tissue 14. 
Immunolocalisation of CML in the IVD, revealed age-dependent CML deposition in areas 
of macroscopic and histological degeneration of the IVD matrix 15. This is in line with age-
dependent accumulation of CML in other tissues consisting of long-lasting matrix proteins 
16-21. Accumulation of CML and other AGE can be recognised by AGE-binding receptors 
such as the multi-ligand receptor RAGE (receptor for advanced glycation end products) and 
the components of the so-called AGE-receptor complex comprising AGE-
R1/oligosaccharyltransferase (OST)-48, AGE-R2/80K-H as well as AGE-R3/galectin-3 22-24 
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. For instance, ligand-binding of RAGE or AGE-R2 have been shown to activate key 
signalling pathways comprising NF-κB, which can potentially result in a proinflammatory 
signalling cascade involving pro-inflammatory cytokines 25,26.   
We hypothesise that accumulation of CML in the ageing IVD matrix might initiate a 
signalling pathway involving NF-κB with resulting consequences to a range of cellular 
functions including the expression of pro-inflammatory cytokines. Alternatively, 
accumulation of AGE/CML on long lasting matrix proteins might be involved in tissue 
remodelling, e.g potentially disrupting protein folding, protein-protein interactions with a 
subsequent brittleness of the extracellular matrix. Matrix metalloproteinase (MMP)-13, a 
collagenase 3, is a candidate proteinase involved in tissue remodelling that can be regulated 
by NF-κB 27-29 and is one of the main proteinases responsible for cleaving collagen type II, 
which is highly abundant in the disc 30-31.  
In using a bovine chondron model32-33, the aim of this study was to examine the 
effects of AGE (CML) on bovine NP cells by investigating i) NF-κB activation, ii) the 
regulation of matix degrading enzymes (e.g. MMP-13) and iii) the expression of pro-
inflammatory cytokines which may play a role in the generation of so-called discogenic 
back-pain 34-37. 
 
Material and methods     
Cell Isolation. Bovine coccygeal spines (n>50) were obtained from the local abattoir (age 
approx. 2 years) and processed within 3 hours of death. The discs were dissected and the 
nucleus tissue carefully separated from the annulus. Discs with damage to the adjacent bony 
endplate were excluded. Nucleus pulposus cells with their pericellular matrix were isolated 
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by 0.2% collagenase IA (Sigma) / 0.3% dispase II (Roche, Applied Science) digestion (w/v 
in PBS). OK medium consisted of 50 % DMEM without glucose (Gibco) and 50 % F12, 2 
% FBS, 1% ITS (Insulin, Transferrin, Selenium; Sigma), and 1 % antibiotic/antimycotic 
(penicillin, streptomycin, amphotericin B;  Gibco). Digestion was carried out overnight at 
37° C (100 % humidity, air, 5 % CO2). Digested tissue and medium were filtered with a 70 
μm cell strainer (Falcon) to remove undigested fragments, washed three times with OK 
medium and resuspended in OK medium. Viable cells, as determined by Trypan blue 
exclusion, were counted and transferred to a 10cm dish.  The cultures were incubated at 37° 
C (100 % humidity, air, 5 % CO2).  The medium was changed after 1 day and every three 
days thereafter. Bovine NP cells were used up to passage 4 in all of our experiments. 
 
Antibodies. Rabbit polyclonal antibody to collagen type VI (Acris Antibodies  GmbH), 
rabbit polyclonal antibody to NF-κB/p65 (C-20, Santa Cruz Biotech),  rabbit polyclonal 
antibody to N-(carboxymethyl)-lysine (CML) (Dr. E. Schleicher,  Tuebingen, Germany), 
goat antibody to RAGE (N-16, Santa Cruz Biotech, Inc.), mouse monoclonal antibody to 
the proliferating cell nuclear antigen (PCNA) (PC-10, Santa Cruz Biotech, Inc), goat 
polyclonal antibody to AGE-R2/Glucosidase II (N-19, Santa Cruz Biotech, Inc.), rabbit 
polyclonal antibody to AGE-R1/OST-48 (H-300, Santa Cruz Biotech, Inc), rat hybridoma 
antibody to AGE-R3/galectin-3 (Prof. A.W. Stitt, Belfast, UK), rabbit polyclonal antibody 
to MMP-13 (Chemicon/Millipore), goat anti rabbit Alexa Fluor 488 antibody (Molecular 
Probes), peroxidase labelled anti mouse/rabbit/rat or goat antibody (Amersham 
Biosciences).      
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Immunohistochemistry. Pepsin-mediated antigen retrieval (Pepsin Solution, Lab Vision 
Corporation) was performed on 5 μm tissue sections at 37°C for one hour and then rinsed in 
PBS. The slides were blocked in 1 % BSA (Sigma), 0.2 % dry milk powder and 0.1 % 
Tween 20 in PBS for one hour, followed by the incubation of a 1:100 dilution of the 
primary antibody in 1 % BSA and 0.1 % Tween 20 in PBS for one hour. Tissue sections 
were rinsed in PBS and incubated for a further 30 minutes with a 1:400 dilution of the 
secondary antibody in 1 % BSA and 0.1 % Tween 20 in PBS. The slides were rinsed again 
in PBS and counterstained with DAPI (1:1000) in PBS for 15 minutes. Sections were 
rinsed, mounted with Vectashield (Vector Lab, Inc, CA) and viewed under the fluorescent 
microscope.  
AGE-BSA preparation. 50 mg BSA Fraction V (Sigma, A-9543) were incubated with 50 
ml PBS, pH 7.4,  and 750 mg of ribose (Sigma) for 5 weeks at 37° C and 5 % CO2 to allow 
AGE accumulation. The solution was dialysed against PBS in two cycles of 6 hours to 
eliminate the ribose.  
CML-BSA preparation. 40 mg BSA Fraction V (Sigma, A-9543) and 40mg 
Glycoaldehyde Dimer (Fluka 50580) were dissolved in 20 ml 0.5 M Na-phosphate buffer, 
pH 7.4, to obtain a concentration of 2 mg/ml. The CML-BSA solution was incubated for 3 
days at 37° C and 5 % CO2 to allow CML accumulation. The concentration of each of the 
modified BSA preparations used to stimulate bovine NP cells for all experiments was 200 
mg/ml. 
Conventional RT-PCR. Total RNA from bovine NP cells and native tissue was isolated 
with the Qiagen RNeasy kit (Qiagen, Germany) and reverse transcription was performed 
using the RT-Statascript kit according to manufacturer’s protocol. For RNA isolation of 
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native tissue; this was snap frozen in liquid nitrogen, pulverised and immediately processed. 
Primer Pairs were designed with the Light-Cycler Probe Design Software 2.0 (Roche 
Diagnostics, Switzerland). The sequences of the bovine primers were: GAPDH 5’ 
TCCGGGAAGCTGTGGCGT 3’ AGGCGGCAGGTCAGATCCACAA, MMP-2 5’ 
GGAACAGATCACATACAGG 3’ CACCAAAGGAAGCCATCG, HIF-1α 
5’GAGGTGGATATGTCTGGATAGAAACTCAAG 
3’AACTGGTTTGAGAACACATTCTGTTTGTTGAAG, collagen type II 5’ 
ATCCATTGCAAACCCAAAGG 3’ CCAGTTCAGGTCTCTTAGAG, collagen type VI 5’ 
CGCTGTGCAACCACGAA 3’ TCCATCTGTTTGGCAGGG,  
Briefly, denaturation at 94° C for 3 minutes, amplification of 30 cycles with denaturation at 
94° C for 40 seconds, primer-dependent annealing temperature for 40 seconds and 
elongation at 72° C for 20 seconds. All PCR products were resolved by 1.5 % agarose gel 
electrophoresis, and the DNA bands were visualised by staining the gel with ethidium 
bromide. Semi-quantification was performed using a Versa-Doc TM Imaging System (Bio-
rad). The values were normalized relative to the reference gene GAPDH to compensate for 
differences in cDNA loading.     
Nuclear and Cytoplasmic Extract preparation and immunoblotting. Nuclear and 
cytoplasmic extracts and immunoblotting were performed as described by Hottiger et al. 
(1998). 
Quantitative PCR (RT-qPCR). Total RNA from bovine NP cells was extracted with the 
RNA isolation kit from Agilent according to the manufacturer’s instructions. cDNA was 
synthesized from 10 ng of total RNA using High Capacity cDNA Archive Kit (Applied 
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Biosystems). The cDNA was mixed with TaqMan Universal PCR Master Mix (Applied 
Biosystems) and a gene-specific primer and probe mixture (Customed TaqMan Gene 
Expression Assays, Applied Biosystems). All samples were biological triplicates run in 
duplicate. Relative expression levels were determined using a four-point serially diluted 
standard curve generated from cDNA from bovine NP cells. Expression levels were 
expressed in arbitrary units, setting the untreated value as 1. The values were normalized 
relative to the reference gene S18 protein mRNA to compensate for differences in cDNA 
loading.  
 
Results 
Isolation of bovine nucleus pulposus-derived chondrons 
First, we determined the feasibility of isolating NP cells with their PCM. According 
to the terminology, in cartilage, cells plus PCM are termed chondrons. All discs used in this 
study were morphologically very similar, with a white NP that was clearly distinguishable 
from the annulus fibrosus. Morphology of the IVD was comparable to grade II human discs 
according to Thompson’s scale 39. Digestion of NP tissue with 1 % collagenase-only or with 
a mixture of 0.3 % dispase/0.2 % collagenase (adapted from Larson et al., 2002) led either 
to preparations containing mostly chondrons or to chondrocyte-like single cell preparations, 
respectively (Fig. 1B  and C). The presence of the pericellular matrix was confirmed by 
immunolocalisation of collagen type VI, which has been shown to be preferentially 
localised in the PCM 41. Viability of the cells was always higher than 90 % as determined 
by Trypan blue exclusion. Comparisons between chondron suspension and native NP tissue 
revealed a very similar distribution and expansion regarding collagen type VI positive 
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matrix (Figure 1A and 1B). The immunofluorescence data was further corroborated by RT-
PCR for collagen VI (Figure 1D, lanes 4 and 8). This suggests the presence of the PCM in 
the chondron suspension used for subsequent monolayer culture. 
Additional phenotypical characterization of the NP chondrons was performed using RT-
PCR for matrix metalloproteinase (MMP)-2, hypoxia inducing factor (HIF)-1α and 
collagen type II. These markers were present in chondrons (Figure 1D, lanes 1-3) as well as 
in the control, native NP tissue (Figure 1D, lanes 5-7). Additionally, the phenotypic 
characterisation of bovine chondrons expanded in a monolayer at passage 4 also showed 
comparable mRNA levels to freshly isolated chondrons (data not shown).  
 
AGE-receptor profiling on AGE/CML-BSA stimulation 
To determine which AGE-receptors are expressed and whether their expression is 
affected by AGE or CML treatment, chondrons were stimulated for 24 or 48 hours with 
AGE/CML-BSA and analysed by immunoblotting (Figure 2). To ensure that the receptor 
profile was not disrupted or modified during the enzymatic isolation, it was monitored on 
native NP tissue and freshly isolated chondrons using conventional RT-PCR (data not 
shown). The AGE receptor complex components were present in the native tissue whereas 
RAGE could not be detected in neither samples, at mRNA or at protein level (data not 
shown). As a positive control for RAGE, bovine lung tissue was used. There were no 
differences between stimulation for 24 (Figure 2) and 48 hours (data not shown). For AGE-
R3 two distinct bands could be detected at approximately 30 and 70 kDa (as indicated by 
the arrows in Figure 2), which would correspond to the monomer and dimmer, respectively. 
In addition, the presence of the several receptors for AGE was monitored in human biopsies 
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of pathological IVDs by RT-PCR. The data corroborated the bovine data on the presence of 
the AGE receptor complex units in the human IVDs (data not shown).  
 
NF-κB subunit p65 translocation into the nucleus 
To study the translocation of NF-κB into the nucleus upon stimulation with 
AGE/CML-BSA, nuclear and cytoplasmic extracts were prepared for samples stimulated 
with AGE-BSA or CML-BSA for 20 minutes (Figure 3A, top panel). PCNA served as a 
loading control for the nuclear extracts, Figure 3A, lower panel. In untreated NP cells no 
NF-κB induction, i.e. translocation into the nucleus, was observed. Induction of NP cells 
with AGE and CML-BSA lead to NF-κB/p65 translocation into the nucleus. 1 μg/ml TNFα 
treatment served as a positive control for NF-κB/p65 translocation into the nucleus, which 
is indicative of its activation. 
 
Effects of AGE/CML-BSA on MMP-13 gene expression 
To determine whether AGE or CML have an effect on MMP-13 gene expression, 
MMP-13/collagenase 3 was monitored upon the stimulation with AGE/CML-BSA. At 6 
hours MMP-13 was strongly induced, in its pro-form, upon CML- BSA (Figure 3B). Again, 
bovine lung tissue served as a positive control for MMP-13 in both forms the pro and 
mature form, 60 and 48 kDa bands respectively.  
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Pro-inflammatory cytokines in AGE/CML-BSA signalling pathway 
Real-time PCR enabled the quantification of pro-inflammatory cytokines that could 
be involved in disc degeneration; these included, IL-6, TNF-α and IL-1β (Figure 4). 
Chondrons were stimulated for 3 or 6 hours under conventional culturing conditions. 
Despite being present in all cultures at basal levels, neither TNF-α, IL-6 nor IL-1β gene 
expression levels varied significantly upon AGE-BSA or CML-BSA treatment. TNF-α 
stimulation was performed as a positive control for the induction of IL-1β and TNF-α gene 
expression whereas LPS stimulated IL-6 mRNA levels.  
 
Discussion 
The source and origin of discogenic back-pain are as yet widely unknown. However, 
there is a consensus that degenerative changes in the matrix of the IVD are of primary 
importance 15, 42-45 , even though the link between morphological alterations in the matrix 
and pain induction is still unclear. Recently, there has been a growing interest in the 
expression of cytokines in the disc matrix that might have contributed to degeneration or 
pain induction 34-37 as well as disruption in the levels of proteolytic enzymes, which are in 
charge of the maintenance of tissue homeostasis 45-47. Post translational non-enzymatic 
modifications such as advanced glycation end products (AGE) also result during the 
processes of ageing and degeneration 15-21. In a histological study, Nerlich et al. have 
observed that post-translational protein modifications such as for example the irreversible 
formation of CML in collagen fibers accumulate with progressive disc degeneration 15.  
AGEs can be recognised by several receptors for AGE and ligand binding can lead to 
activation of NF-κB with consequences to a range of cellular functions, including the 
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induction of pro-inflammatory cascades 23, 48 and matrix metalloproteinases. These findings 
suggest that CML or AGE accumulation might be the starting point of a signalling cascade, 
connecting age-dependent matrix alterations to the expression of matrix degrading 
proteinases. Expression of the cytokines might then lead to pain induction responsible for 
discogenic low back-pain.  
Investigations on molecular signal transduction events leading to CML accumulation in the 
disc in vivo is hampered by the limited possibilities of influencing the conditions inside the 
IVD. In this study, a monolayer culture system based on easily accessible bovine IVD NP 
cells was used as it has been shown to be phenotypically similar to human NP cells 32. To 
minimise the disturbances to the cells, NP cells were isolated as ‘chondrons’ 33, 40, i.e. IVD 
cells covered by their pericellular matrix. As high glucose levels are not present in the in 
vivo situation and might lead to artificially high levels of glycated matrix proteins in vitro, 
glucose levels were reduced to 5 mM and fetal calve serum was reduced to 2 % with the 
addition of 1 % ITS. ITS as a serum replacement, has been successfully used in articular 
cartilage as it promotes a reduced chondrocyte differentiation and higher quality of tissue 
formation 49-50. Phenotypic stability of the isolated disc cell chondrons expanded as a 
monolayer cultures was assessed throughout the experiments.  The presence of the PCM 
and success of our isolating method was determined by collagen type VI. In addition, 
phenotypic stability was examined in freshly isolated as well as expanded chondrons; 
passage 4 shared the same phenotypical properties of the native tissue like disc cell markers 
such as MMP-2, HIF-1α and collagen type II. Taken together, the data suggest that the 
chondron-based system might be a suitable model to culture disc cells in vitro. 
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Identification of the receptors involved in AGE-ligand binding in the IVD was analysed 
after stimulation of cultured chondrons with either AGE- or CML-BSA. A screening was 
performed using immunoblotting and conventional RT-PCR by examining the receptor for 
AGE (RAGE), and the components of the so-called AGE-receptor complex. However, 
expression at gene and protein level of RAGE could NOT be detected either in the bovine 
chondrons or in the native bovine tissue. To avoid any species-specific differences between 
the bovine cells applied in this study and human IVD cells, human IVD biopsies were 
assessed in parallel. The presence of RAGE mRNA could not be detected in any of the 6 
human degenerated intervertebral biopsies despite being present in the human lung as 
analysed by RT-PCR (data not shown). The discrepancy of our results with other studies 26, 
51 with regard to the absence of RAGE in human degenerated IVD should be further 
analysed and immunohistochemical studies interpreted with care. Additional AGE receptors 
that might substitute for RAGE have been described recently. The so-called AGE-receptor 
complex was first described by Li et al. in 1996 and consisted of AGE-R1 / OST-48, AGE-
R2 / 80K-H and AGE-R3 / galectin-3. The subunits of the AGE-receptor complex were 
present in disc chondrons (Figure 2) and native tissue (data not shown) but were not 
induced on stimulation by AGEs as no changes were detected at protein level compared to 
the basal level before stimulation. Interestingly, two bands were detected for AGE-R3, most 
likely representing the monomer and dimer form of AGE-R3 as previously published 52.  
Our results indicate that an NF-κB-dependent pathway is indeed activated as NF-
κB/p65 was translocated into the nucleus on AGE/CML-BSA stimulation. To investigate if 
glycated proteins do have the ability to induce the expression of potentially NF-κB-
dependent proinflammatory cytokines, expression levels of IL-6, IL-1β and TNF-α were 
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analysed after incubating chondrons to AGE- or CML-modified proteins (BSA). 
Surprisingly, neither exposure to AGE- or CML-BSA did significantly affect the gene 
expression levels of the investigated cytokines. Only mild effects such as one fold increase 
upon stimulation for IL-6 and IL-1β were observed. This is in contrast to previous studies 
revealing that AGE/CML are potent inducers of a proinflammatory cascade in other cell 
types 25-26.  
Contrary to the findings regarding cytokine expression and AGE-receptor activation, 
the nature of the advanced glycation end products does seem to influence differently tissue 
remodelling processes by modulating MMP expression. MMPs have been reported to be 
important factors in the catabolic processes involved in matrix turnover in the IVD. 
Homeostasis is a key feature in this turnover between matrix proteins, matrix degrading 
proteins and their inhibitors. MMP-13 or collagenase 3 was analysed as it can be regulated 
by NF-κB 27-29 and is one of the main proteinase responsible for the degradation of collagen 
type II 30, 31. Our results indicate that CML-BSA upregulates the protein levels of the pro-
form of MMP-13, which is active but can be cleaved to a more active mature form when 
released into the ECM. An upregulation of MMP-13 would then tip the balance to catabolic 
processes severly affecting tissue turnover.  
Clinical relevance. The presence of glycated proteins did not stimulate the expression of 
pro-inflammatory cytokines or affect the expression or activation of putative receptors for 
the presence of AGE. However, the activation, possibly via NF-κB, of a major proteinase 
involved in tissue remodelling of the IVD matrix suggests an important role for AGE 
modified proteins during degeneration of the IVD.  
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Legends 
 
 
Figure 1. Phenotypical Characterisation of the bovine native nucleus pulposus tissue and chondron 
suspensions derived from bovine NP. Immunolocalisation of collagen type VI in native bovine NP tissue 
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(A), NP-derived cell (B) or NP-derived chondron (C) suspensions (blue = nuclear stain with DAPI, green = 
collagen type VI). Original magnifications were 100 x for A and 40 X for B and C. Characterisation using 
RT-PCR of the native bovine NP tissue and the bovine chondron suspension (D). Columns 1-4 and 5-8 
correspond to native NP tissue and chondron suspension, respectively. Columns 1 and 5 correspond to 
MMP-2, 2 and 6 to HIF-α, 3 and 7 to Collagen type II and 4 and 8 to Collagen type VI. 
 
 
Figure 2. Expression of AGE receptors upon stimulation with AGE/CML-BSA. Bovine chondrons were 
stimulated with either AGE or CML-BSA for 24 hours. Immunoblotting was performed to detect the 
presence of AGE-R1/2/3 and RAGE in bovine NP cells. Bovine lung tissue served as a positive control for 
RAGE. 
 
 
Figure 3. p65NF-κB translocation into the nucleus and MMP-13 expression in bovine nucleus 
pulposus cells stimulated with AGE/CML-BSA. Panel A corresponds to p65NF-κB translocation into the 
nucleus of bovine NP cells. The nuclear extracts were analysed by immunoblotting. UT stands for untreated. 
TNF-α (1μg/ml) stimulated cells served as positive control. PCNA served as a loading control. This panel 
represents three independent biological replicates (n=3). Panel B corresponds to Western blot analysis of 
whole cell extracts of bovine NP cells stimulated with either AGE-BSA or CML-BSA for 6 hours to detect 
MMP-13. Bovine lung tissue served as a positive control. The molecular weight of the precursor and mature 
form of MMP-13 are 60 and 48 kDa, respectively. This panel represents three independent biological 
replicates (n=3). 
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Figure 4. Pro-inflammatory cytokine profile of bovine nucleus pulposus cells stimulated with 
AGE/CML-BSA. All experiments were performed under normal culturing conditions. The cytokine profile 
for IL-6, IL-1β and TNF-α was analysed using quantitative real-time RT-PCR. NP cells were stimulated 
with either AGE/CML-BSA. TNF-α and LPS stimulated cells served as a positive control showing that the 
above mentioned cytokines can be indeed induced. On the y and x axis the fold increase and the time point in 
hours is represented, respectively. Expression levels were expressed in arbitrary units, setting the untreated 
value as 1. The values were normalized relative to the reference gene S18 protein mRNA to compensate for 
differences in cDNA loading. This figure represents a mean of at least three independent biological samples. 
 
 
Poveda, et al.,Figure 1
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Poveda, et al.,Figure 3
 
Poveda, et al.,Figure 4
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Peroxynitrite induces gene expression in 
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Peroxynitrite induces gene expression in intervertebral disc cells.  
 
 
Abstract 
 
Objective: To investigate the oxidative/nitrosative effects of peroxynitrite on human 
nucleus pulposus cells. 
Background Data: Peroxynitrite is an important tissue-damaging species generated at sites 
of inflammation and degeneration. The aim of this study was to examine the effects of 
oxidative/nitrosative stress caused by peroxynitrite and the peroxynitrite donor SIN-1 in 
human nucleus pulposus cells. 
Methods: Degenerated human intervertebral disc tissue was analysed for nitrosylation by 
immunofluorescence. In addition, human nucleus pulposus cells were isolated from 
intervertebral discs, expanded and stimulated either with peroxynitrite itself or a stable 
peroxynitrite donor (SIN-1). Nitrosylation, accumulation of intracellular reactive oxygen 
species, NF-κB nuclear translocation and cell viability were analysed by fluorescence. Gene 
expression of TNF-α, IL-1β, IL-6, IL-8 and IL-10 was quantified by real-time RT-PCR.  
Results: Degenerated intervertebral disc tissue showed strong nitrosylation, especially in the 
nucleus pulposus. Isolated human nucleus pulposus cells showed a strong signal for 
nitrosylation and intracellular ROS upon stimulation with peroxynitrite or SIN-1. NF-
κB/p65 sustained nuclear translocation of NF-κB/p65 and stimulation of IL-1β, IL-6 and 
IL-8 expression was noted upon treatment of cells with SIN-1. 
Conclusions: This study provides evidence that peroxynitrite may play a role in disc 
degeneration by an increased synthesis of pro-inflammatory cytokines. Nuclear 
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translocation of NF-κB was identified as the potential underlying pathway. Thus, 
neutralising peroxynitrite and its derivatives (e.g. via the use of antioxidants) may be a 
novel treatment approach to deal with inflammatory processes and discogenic degeneration.  
 
 
Key words: 
Intervertebral disc, degeneration, peroxynitrite, SIN-1, NF-κB activation, tyrosine nitration, 
pro-inflammatory cytokines. 
 
Key points:  
1. Tyrosine nitration due to oxidative/nitrosative stress is present in the human degenerated 
intervertebral disc. 
2. Peroxynitrite is a highly reactive agent formed in vivo from the interaction of superoxide 
and NO. 
3. Peroxynitrite and SIN-1 (a stable peroxynitrite donor) induce nitrosylation in NP cells as 
well as the activation of an NF-κB-dependent signalling pathway, resulting in the 
upregulation of pro-inflammatory cytokines. 
 
 
 
Mini abstract: 
The presence of nitrosylation in degenerated intervertebral discs suggests a role of reactive 
oxygen/nitrogen species in the process of disc degeneration. In human nucleus pulposus 
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cells, peroxynitrite and SIN-1 stimulated expression of pro-inflammatory cytokines which 
correlated with sustained nuclear translocation of NF-κB.  
 
 
 
INTRODUCTION 
Disc degeneration is an age-related process which can start as early as the second 
decade of life [1]. It is widely accepted, although not conclusively proven, that the level of 
oxidative stress increases with ageing, possibly by inducing damage of macromolecules and 
disrupting the homeostasis between reactive oxygen and nitrogen species production and 
anti-oxidant defences. This sets the basis of the ‘free radical theory of ageing’  where 
organisms ‘age’ due to the accumulation of free radical damage as time passes [2, 3]. 
Moreover, a variety of inflammatory mediators have been implicated in intervertebral disc 
(IVD) degeneration or pain induction such as the expression of cytokines in the disc matrix 
[4-7]. Special attention however, has recently been drawn towards reactive oxygen and 
nitrogen species for their role in disc degeneration and sensitisation of dorsal root ganglion 
neurons [8, 9]. While free radical species have been shown to contribute to vital cell 
signalling mechanisms, there is evidence for a detrimental effect of these highly reactive 
and labile molecules in tissues such as cartilage with their implication in cell senescence 
[10-12], inhibition of proteoglycan synthesis as well as general degeneration of the 
extracellular matrix, i.e. damage of structural ECM proteins and activation of ECM 
proteinases [13, 14]. Furthermore, in degenerated cartilage, reactive oxygen and nitrogen 
species have been shown to correlate with high levels of pro-inflammatory cytokines such 
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as IL-1β [15]-[16]. Several reports have investigated the presence of free radical 
components such as nitric oxide (NO) and inducible nitric oxide synthase (iNOS) in the 
degenerating and herniated disc [5, 17]. Using a cell culture model, human nucleus 
pulposus (NP) cells have been shown to produce RNS [8, 18]. 
 Peroxynitrite is a highly reactive agent formed in vivo from the interaction of 
superoxide and NO [19]. Peroxynitrite causes generalised oxidative damage, e.g. it. reacts 
with DNA, lipids and proteins [20-25]. Therefore, peroxynitrite is able to disturb many 
cellular processes, including an enhancement of NF-κB-mediated pro-inflammatory signal 
transduction pathway [26, 27]. However, it cannot be directly measured in vivo due to its 
nature, formation and decomposition resulting in a short half-life and low steady 
concentration, but secondary markers can be used, such as the ability of peroxynitrite to 
nitrosylate tyrosine residues [28]. There are several lines of evidence for the formation of 
peroxynitrite in biological systems which include the presence of peroxynitrite detoxifying 
enzymes and the kinetically and thermodynamically favoured reaction between superoxide 
and nitric oxide. To date there is no data on the presence of peroxynitrite in the 
intervertebral disc.  
Nuclear factor kappaB (NF-κB) plays an important role in the transcriptional 
regulation of genes involved in inflammation. In resting cells, NF-κB is maintained in an 
inactive state in the cytoplasm. In response to pro-inflammatory stimuli, translocation of the 
NF-κB subunits (p65/p50) to the nucleus is rapidly observed at the site where transcription 
is initiated upon binding of NF-κB to the promoter regions of responsive genes.  
The aim of this study is to examine whether peroxynitrite plays a role in the 
inflammatory cascade, possibly involving NF-κB, which may lead to painful disc 
 79
                                                                                                                                                                     Results 
degeneration. In order to mimic the in vivo continuous flux of peroxynitrite, the 
peroxynitrite donor 3-morpholinesydnonimine (SIN-1) was used since it slowly 
decomposes to release both superoxide and NO which react together to produce  
peroxynitrite. 
 
METHODS 
Cell isolation and culture. Intervertebral disc tissue was obtained from a total of 6 patients 
(Table 1) and used for either cell culture or formaldehyde fixation. All specimens were 
collected under informed consent and approved by the institutional review board. Nucleus 
pulposus cells with their pericellular matrix (i.e. chondrons) were isolated by overnight 
digestion with 0.2% collagenase Ia (Sigma, Switzerland) and 0.3% dispase II (Roche 
Diagnostics, Switzerland) in PBS (w/v) (37°C, 5 % CO2). Digested tissue was filtered (70 
μm cell strainer, BD Bioscience, Switzerland) and washed three times with DMEM/F12 
medium. Cells were expanded up to passage three in monolayer using DMEM/F12 medium, 
containing 10 % FCS, penicillin (50 units/ml), streptomycin (50 µg/ml), ampicillin (125 
ng/ml) (Invitrogen, Switzerland) with medium changes twice a week. 
Cell stimulation. Normal medium was replaced by serum-free medium containing 3-
morpholinesydnonimine (SIN-1, 1 mM) (Sigma, Switzerland) or 100μM peroxynitrite 
(Millipore, Temecula, CA, USA) and 2% ITS (Insulin, Transferrin, Selenium) as serum 
replacement (Sigma, Switzerland) and cells were stimulated for 2, 4 or 6 hours for gene 
expression, viability and nitrosylation assays.  
Analysis of cell viability. Viability of cells treated with SIN-1 or peroxynitrite was 
assessed by fluorescence staining using calcein-AM (2 μM, Sigma, Switzerland) and 
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ethidium homodimer-1 (2 μM, Sigma, Switzerland) after 2, 4 and 6 hours. Ethidium 
homodimer-1 only enters cells with compromised cell membranes and intercalates with 
nucleic acids producing red fluorescence. Calcein-AM penetrates the membranes of living 
cells where cytoplasmic esterases cleave the molecule producing green fluorescence. Thus, 
live cells are depicted green and dead cells red. The percentage viability was calculated 
manually counting the number of live cells and dividing by the total number of cells 
visualised per field.  
Analysis of nitrotyrosine (immunohistochemistry). Intervertebral disc tissue from two 
patients undergoing discectomy (Table 1) for degenerative disc disease was analysed to 
verify the pathological occurrence of nitrosylation in vivo. Tissue was fixed, embedded in 
paraffin, cut (5 μm) and pepsin-mediated antigen retrieval (Pepsin Solution, Lab Vision 
Corporation, UK) was performed at 37°C for one hour. Sections were then rinsed in PBS 
and permeabilised with Triton-X (0.2% in PBS). In addition, human NP cells grown on 
glass slides were stimulated with SIN-1 for 2, 4 or 6 hours, fixed with 4% formaldehyde 
and permeabilised as described above. Both, cells and tissue sections, were blocked in 1 % 
BSA (Sigma, Switzerland), 0.2 % dry milk powder and 0.1 % Tween 20 in PBS for one 
hour, followed by incubation with rabbit polyclonal antibody to nitrotyrosine (Millipore, 
Temecula, CA, USA, 1:100 dilution) in 1 % BSA and 0.1 % Tween 20 in PBS for one hour. 
Slides were rinsed in PBS and incubated for 30 minutes with the secondary antibody goat 
anti rabbit Alexa Fluor 488 (Molecular Probes, Switzerland, 1:400 dilution). They were 
then rinsed in PBS and nuclear counterstaining was performed using DAPI (Sigma, 
Switzerland) in PBS (1:1000) for 15 minutes. Slides were again rinsed, mounted with 
Vectashield (Vector Lab, Inc, CA, USA) and viewed under the fluorescent microscope. As 
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a positive control, cells were treated with 100 μM peroxynitrite (Millipore, Temecula, CA, 
USA). 
Analysis of intracellular reactive oxygen and nitrogen species. Human NP cells were 
treated as described for nitrosylation analysis. In brief, cells were incubated in the dark for 
30 minutes in PBS containing 10μM 5-(and-6)-chloromethyl-2’,7’-
dichlorodihydrofluorescein diacetate (CM-H2DCFDA; Sigma). The ROS generation was 
detected as a result of the oxidation of DCFH (excitation, 488nm; emission, 515-540nm).  
Samples were mounted onto slides and imaged under the fluorescence microscope. 
Analysis of NF-κB/p65 translocation (immunohistochemistry). Human NP cells were 
treated as described for nitrosylation analysis. NF-κB/p65 nuclear translocation was 
analysed using a rabbit polyclonal antibody to NF-κB/p65 (C-20, Santa Cruz Biotech). As a 
positive control, cells were treated with TNF-α (10 ng/ml) which has been previously 
shown to induce NF-κB/p65 nuclear translocation. 
Gene expression analysis (real-time RT PCR). Cell cultures were stimulated for 2, 4 and 
6 hours with SIN-1 (1mM) and total RNA was isolated using a Miniprep Kit (Sigma, 
Switzerland) according with the manufacturer’s instructions. cDNA was synthesised from 
10 ng of total RNA using High Capacity cDNA Archive Kit (Applied Biosystems, 
Switzerland). Human specific probes and primers for IL-1β, IL-6, IL-8, IL-10 and TNF-α 
(Applied Biosystems, Switzerland) were used for real-time RT-PCR with RG-3000A 
(Corbett Research). The comparative ct method was used to calculate changes in gene 
expression, additionally using a standard curve (generated from cDNA from human NP 
cells) to include PCR efficiency in the calculations. Briefly, expression of genes of interest 
was normalised versus expression of TATA binding protein (TBP) (∆Ct) and thereafter 
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versus untreated conditions (= 0 hours) (∆∆Ct). Therefore, expression levels are expressed 
in arbitrary units, setting the untreated value to 1.  
Statistical analysis. Gene expression results were tested for statistical significance applying 
a t-test with results tested for being different from 1 (= no stimulation) and a significance 
level of p < 0.05.  
 
 
RESULTS 
Nitrosylation in degenerated IVDs.  
Nitrosylation occurs in vivo during intervertebral disc degeneration and is primarily 
located in the NP as shown in Figure 1. Scarce nitrosylation was noted in cells from the AF. 
Cells from the transition zone, which lies between the AF and NP, did show positive 
staining for nitrosylation (Data not shown). A 100x magnification picture of a NP cell 
shows in detail the tyrosine nitration intracellular staining.   
 
 
 
 
Patient 
number 
Sex Age (years) Pathology of IVD Levels 
1 Male 25 herniation/sequestered L4/L5 
2 Male 14 traumatic fracture L4/L5 
3 Male 40 traumatic fracture L5/S1 
4 Female 37 Herniation L5/S1 
5 Male 56 Degeneration L5/S1 
6 Female 63 Degeneration L4/L5 
Table 1. Demographical data of the IVD donor and their correspondent pathology. 
 
 83
                                                                                                                                                                     Results 
 
 
Nitrosylation in NP cells.  
Upon treatment with SIN-1 or authentic peroxynitrite, nitrosylation was detected at 
6 hours (Fig. 2a). Our unstimulated cells showed none or little staining. Tyrosine nitration 
was further analysed for NP cells and stimulated with SIN-1 for all time points (Fig. 3). 
Nitrosylation was distinctively intracellular. Nevertheless, there was a slight change in the 
pattern of the staining within the time points. For instance, at 2 and 4 hours, the staining 
was mainly cytoplasmic, with a higher intensity in the periphery of the nucleus. At 4 hours 
some cells show nuclear nitrosylation staining whereas at 6 hours most cells give both a 
cytoplasmic and nuclear staining. Thus, indicating that both cytoplasmic and nuclear 
proteins get nitrosylated at their tyrosine residues with increasing time. In addition, NP cells 
stimulated for 14 hours also showed nuclear and cytoplasmic nitrosylation (data not shown).  
 
Intracellular ROS in NP cells.  
A strong CMH2DCFDA staining was observed in NP cells stimulated with either 
SIN-1 or authentic peroxynitrite. Again, unstimulated cells showed a rather weak 
fluorescence staining for CMH2DCFDA (Fig. 2b). The lower cell number of the pictures for 
peroxynitrite and SIN-1 is not due to decreased cell viability but was chosen on purpose by 
plating lower amounts of cells so as to reduce the background of the CMH2DCFDA 
staining.    
 
Cell viability of NP cells.  
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There was no effect observed on the cell viability (>98%) upon stimulation with 
either, SIN-1 or peroxynitrite for 6 hours (Fig. 2c). NP cells remained viable at 96% for at 
least 14 hours of stimulation with SIN-1 (Data not shown).  
 
NF-κB subunit p65 translocation into the nucleus. 
As shown in Figure 3b, NF-κB/p65 was present in the nucleus at 2, 4 and 6 hours, 
becoming more abundant with increasing time. Lime-green arrows indicate a representative 
example of a cytoplasmic staining of NF-κB/p65. Nuclear translocation of NF-κB/p65 
becomes more abundant with increasing time. Blue arrows indicate a typical nuclear 
staining for NF-κB/p65. A positive control was run in parallel with NP cells stimulated with 
TNF-α (data not shown). Furthermore, NF-κB/p65 still remained in the nucleus after 14 
hours of stimulation with SIN-1 (data not shown). 
 
Gene expression on SIN-1 treatment. 
Human NP cells were stimulated for 2, 4 and 6 hours with 1mM SIN-1 and the 
expression of IL-1β, IL-6, IL-8, IL-10 and TNF-α were quantified using real time RT-PCR. 
Interestingly the gene expression pattern varied among the cytokines tested. Gene 
expression for IL-1β gradually increased with time, registering a statistically significant 3.5 
and 4.5 fold increase at 4 and 6 hours, respectively, of treatment with SIN-1. The opposite 
pattern was quantified for IL-6 with a 4 fold increase peak as early as 2 hours of 
stimulation, but returning immediately to basal levels at 4 hours. The pattern of IL-8 was 
similar to IL-6 reaching a 9.75 fold increase at 2 hours stimulation. Nevertheless, cytokine 
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levels remained at a constant 3 fold increase thereafter. Moreover, TNF-α and IL-10 levels 
remained constant and unchanged throughout the treatment for the time points tested. 
 
 
DISCUSSION 
Oxidative stress has long been related to IVD degeneration and other inflammatory 
joint diseases [1, 15, 25, 29]. Whilst most studies focus on the occurrence and effects of 
reactive oxygen species (ROS), reactive nitrogen species (RNS) have been shown to be 
involved in degenerative diseases, although mechanisms and effects are far less understood 
to date, especially with regards to IVD degeneration. So far, research tackling discogenic 
degeneration has mostly dealt with NO and inducible NO synthase (iNOS) [5, 6, 9]; scarce 
or no information is available on peroxynitrite, despite being an even more reactive, 
damaging and toxic species [17]. Peroxynitrite is one of the major damaging oxidants 
produced in mammals during aging, inflammation and neurodegenerative disorders among 
other pathologies. However, its role during IVD degeneration and its putative influence on 
pain initiation is yet unknown. Several of the biological effects of peroxynitrite which could 
be related and involved in disc degeneration include inhibition or depletion of antioxidant 
enzymes, activation of specific enzymes such as matrix metalloproteinases [30, 31], 
impairment of enzyme cofactors (BH4) [32], DNA injury [33]and mitochondrial 
dysfunction [34]. Moreover, peroxynitrite has been shown to also modify receptors, causing 
downstream receptor coupling and signalling with the activation of MAPK pathway, PARP, 
NF-κB, phosphoinositide 3-kinase/Akt, PKCε, cyclo-oxygenase and nerve growth factor 
[35-43].  
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Based on this knowledge, we assumed that peroxynitrate may play an important role during 
IVD degeneration and may, additionally, induce synthesis of pro-inflammatory cytokines 
shown to increase in painful disc degeneration. It is thought that pro-inflammatory 
cytokines can diffuse through the disc via clefts and tears and may therefore irritate nerve 
roots and nerve endings in the epidural space or the outermost part of the annulus fibrosus.  
In order to test this hypothesis, native degenerated IVD tissue was analysed and found to be 
positive for nitrosylation. However, we were not able to analyse nitrosylation in healthy 
IVD tissue in comparison, so we can not conclude that nitrosylation is a process that is 
specific to degenerated tissue. Nevertheless, NP chondron-cells isolated from those same 
discs were only positive for nitrosylation and intracellular ROS when stimulated with 
peroxynitrite or SIN-1.  
In a second step, we performed experiments on cells isolated from human IVD tissue. To 
minimise cellular and phenotypical changes induced by the isolation and expansion, cells 
were isolated with their pericellular matrix (chondrons) and not expanded further than 
passage 3. In this cell culture model, we were able to show that SIN-1, a peroxynitrite 
donor, and authentic peroxynitrite (data not shown) induced gene expression of IL-1β, IL-6 
and IL-8 with distinct patterns for all genes. Whilst IL-1β increased time-dependently, IL-6 
and IL-8 both had a strong initial peak at 2 hours followed by a decrease in the later time 
points tested. Note that gene expression for IL-6 returned to basal levels whereas IL-8 
remained upregulated at 4 and 6 hours. In contrast, no changes in gene expression for IL-10 
and TNF-α could be found; thus highlighting the importance of IL-1β, IL-6 and IL-8 during 
nitrosative stress. Oscillatory wave curves were detected for these three NF-κB-dependent 
cytokines, IL-1β, IL-6 and IL-8, indicating that even though NF-κB might be a shared 
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transcription factor for these genes, the recruitment onto the promoter, its accessibility and 
the involvement of various co-regulators might be rather different, leading to time 
differences. In addition, these cytokines have been related to IVD degeneration and even 
herniation. These findings are in line with a study performed by Le Maitre et al. [44, 45], 
showing that IL-1β but not TNF-α can be detected in human degenerated IVDs.   
In a third step, we aimed to identify the pathway underlying the observed changes in gene 
expression. As nuclear factor kappaB (NF-κB) plays an important role in the transcriptional 
regulation of genes involved in inflammation, we hypothesised its involvement in this pro-
inflammatory cascade. We were able to show NF-κB/p65 nuclear translocation due to 
stimulation with SIN-1, suggesting the involvement of NF-κB during oxidative stress as 
simulated in this cell culture model. Interestingly, NF-κB/p65 nuclear localisation was not 
transient, but was observed to increase throughout the time points tested and was still 
present after 14 hours (data not shown). Therefore, peroxynitrite stimulation does not seem 
to act on the so-called canonical or classical pathway. Instead an alternative mechanism of 
NF-κB activation seems to be taking place under prolonged exposure of NP cells to 
peroxynitrite. This pathway would consist of the constitutive activation of NF-κB through 
the tyrosine nitration of I-κB [46, 47] which has been already described in detail in other 
tissues/cells such as in muscle myoblasts [27]. Long term exposure to peroxynitrite leads to 
the nitration of I-κB which inhibits its degradation by the ubiquitin and proteasome pathway 
and thereby activates continuous and non-transiently NF-κB [48] [49]. The continuous and 
long term activation of NF-κB may exacerbate the inflammatory responses mediated by this 
transcription factor. 
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Our results suggest that oxidative/nitrosative stress caused by peroxynitrite might play an 
important role in the development and persistence of discogenic inflammation as it activates 
an NF-κB dependent signal transduction pathway and promotes enhanced gene expression 
of NF-κB dependent cytokines [50], related to IVD degeneration. Significantly, this effect 
was not only transient, but was persistent, therefore highlighting its potential importance in 
prolonged inflammatory states. Antioxidant treatment or tyrosine nitration inhibition might 
become a treatment option for disc degeneration and related discogenic pain. 
In conclusion, our study suggests that peroxynitrite may play a role in the 
inflammatory cascade occurring during disc degeneration and could eventually lead to 
discogenic back-pain.  
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LEGENDS 
 
Figure 1. Nitrosylation in the human native nucleus pulposus tissue and annulus 
fibrosus. Immunolocalisation of nitrosylation in native human AF (first column) and NP 
tissue (second column). Pictures in the third row correspond to a picture in a higher 
magnification (100x) of NP cells in the native tissue (blue = nuclear stain with DAPI, red = 
nitrosylation).  
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Figure 2. Reactive oxygen/nitrogen species in human nucleus pulposus cells cultured 
with either peroxynitrite or SIN-1 for 6 hours. Immunolocalisation of nitrosylation 
(Panel A), or intracellular reactive oxygen/nitrogen species (Panel B) in human NP cells 
stimulated for 6 hours with either 100μM peroxynitrite or 1mM SIN-1. The cells were 
counterstained in Panel A and Panel B with DAPI and ethidium bromide, respectively. Cell 
viability (Panel C) was performed using calcein-AM (green = viable cells) and ethidium 
homodimer (red = dead cells). 
 
Figure 3. Effects of SIN-1 in human nucleus pulposus cells. Immunolocalisation of 
nitrosylation (Panel A) or NF-κB/p65 nuclear translocation (Panel B) in NP cells cultured 
for 0, 2, 4 and 6 hours with 1mM SIN-1. Nuclear counterstain was obtained with DAPI. The 
lime-green arrow corresponds to a typical cytoplasmic staining whereas the blue arrow 
indicates an example for a nuclear staining. 
 
Figure 4. Pro-inflammatory cytokine profile of human nucleus pulposus cells 
stimulated with SIN-1. All experiments were performed under normal culturing 
conditions. The cytokine profile for IL-1β, IL-6, IL-8, IL-10 and TNF-α was analysed using 
quantitative real-time RT-PCR.  On the y and x axis, the fold increase and the time point in 
hours is represented, respectively. Expression levels were expressed arbitrary units, setting 
time 0 hours value as 1. The values were normalised relative to the reference gene TBP to 
compensate for differences in cDNA loading. This figure represents a mean of at least five 
biologically independent samples. * corresponds to p < 0.05, all p values were relative to 
time 0 hours. 
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6. Unpublished results 
 
6.1. Environmental condition-dependent accumulation of N-(carboxymethyl) lysine (CML) 
and expression of RAGE (receptor for glycation end products) in a chondron-based pellet 
culture system of bovine nucleus pulposus cells. 
 
6.1.1. Introduction and aim 
Recently, Nerlich et al. investigated occurrence of the post-translational protein 
modification N-(carboxymethyl) lysine (CML) in autopsy specimens of lumbar 
intervertebral discs from individuals of different age groups and stages of degeneration [25]. 
CML has been shown to emerge from so-called advanced glycation end products (AGE) 
after a series of oxidation and rearrangement steps [325-327]. Overall, CML may serve as a 
biomarker of general oxidative stress [328]. Immunolocalisation of CML in the 
intervertebral disc revealed age-dependent CML deposition in areas of macroscopic and 
histological degeneration of the IVD matrix [25]. This agrees with age-dependent 
accumulation of CML in other tissues consisting of long-lasting matrix proteins [329-331]. 
Accumulation of CML and other AGE is recognised by the multi-ligand receptor RAGE 
(receptor for advanced glycation end products), a member of the immunoglobulin 
superfamily [113, 114]. Ligand-binding of RAGE has been shown to activate key signalling 
pathways such as NF-κB, potentially resulting in a pro-inflammatory signalling cascade 
involving pro-inflammatory cytokines [113].  
We hypothesise that accumulation of CML in the ageing intervertebral disc matrix might 
initiate a signalling cascade that finally results in the expression of pro-inflammatory 
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cytokines, which might be responsible for the induction of discogenic low back-pain. 
Analysis of the environmental conditions leading to CML accumulation in vivo is hampered 
by the limited possibilities to explore such conditions inside the IVD in vivo. Investigations 
on the signalling cascade within the disc therefore require the application of cell culture 
models. Bovine IVDs as a cell source are advantageous because i) they are phenotypically 
similar to human nucleus pulposus cells, ii) the IVDs are easily accessible, and iii) the 
heterogeneity in the cell population is much less a problem than in normal adult discs which 
can exhibit a larger variation in degenerative changes [148, 332, 333]. In an attempt to 
avoid the introduction of foreign matter and to preserve the original phenotype/environment 
of disc cells, we made use of the natural self-organising, pellet-forming capability of disc 
cells. A carrier-free 3-dimensional culture system was used which allowed disc cell self- 
rearrangement, production of ECM and above all to preserve the original 
phenotype/environment of disc cells by isolating disc cells with their PCM (chondrons).  
 In using a bovine chondron-based cell culture model, we investigated the accumulation of 
CML and expression of RAGE after subjecting the pellet cultures to various environmental 
conditions which may resemble the aggravated environment that disc cells might encounter 
during the process of degeneration. 
 
 
6.1.2. Results 
Isolation of bovine nucleus pulposus-derived chondrons. First, we determined the 
feasibility of isolating NP cells with their pericellular matrix (PCM). According to the 
terminology in cartilage, cells plus PCM are termed chondrons. All discs used in this study 
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were morphologically very similar, with a white NP that was clearly distinguishable from 
the AF. Morphology of the discs was comparable to Grade II discs according to Thompson 
et al. [31]. 
Digestion of NP tissue with 1 % collagenase-only or with a mixture of 0.3 % dispase/0.2 % 
collagenase (adapted from [334]) led either to chondrocyte-like single cell preparations or 
to preparations containing mostly chondrons. The presence of the pericellular matrix was 
confirmed by immunolocalisation of collagen type VI, which has been shown to be 
preferentially localised in the pericellular matrix of disc cells and was mostly absent in the 1 
% collagenase-only digested cultures [335] (Fig. 5A and B). This suggests the presence of 
the PCM in the chondron suspension used for subsequent pellet formation. 
Immunodetection of collagen type II, a marker for the differentiated disc cell phenotype, 
revealed that the nucleus pulposus-derived cell suspension versus the chondron suspension 
had a slightly higher expression of collagen type II (Fig. 5C – G). Note the accumulation of 
collagen type II at certain foci around the cell (Fig. 5G). Viability of the cells was generally 
higher than 98% as determined by Trypan blue exclusion. 
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Figure 5. Immunolocalization of collagen type VI and II in cell and chondron suspensions of nucleus 
pulposus tissue. Immunofluorescence staining to detect collagen type VI chondron-suspension (A) and cell-
suspension (B). Collagen type VI is detected as a halo surrounding the cell (green), cell nuclei were 
counterstained with DAPI (blue). C and D: cellular distribution of collagen type II in chondron (C) or cell (D) 
suspensions. E and F: corresponding nuclear stain with DAPI. G: foci of collagen type II accumulation (red = 
collagen type II, blue = nuclear staining DAPI). Original magnification: A – D: 20 x, E: 40 x  
 
 
Routine histology revealed notochordal-like cell clusters in cell and chondron suspensions 
(Figure 6).  
  
Figure 6. Notochordal-like cell clusters in NP-derived cell or chondron suspensions. Haematoxylin and 
eosin staining revealed notochordal-like cell cluster in cell (A) and chondron (B) suspensions. Original 
magnification: 40 x 
 
 
Pellet formation from NP-derived chondrons. Within seven days of the onset of the 
experiment the pellets were readily formed. At four weeks, the pellets were removed from 
the medium and processed for routine histology. Haematoxylin and eosin staining revealed 
the spherical shape of the pellets with the cells embedded in considerable amounts of 
extracellular matrix (Fig. 7). Proteoglycan, an important component of the NP extracellular 
matrix was found present in the pellet matrix as detected by histology (Fig.8 A). Several 
cells were surrounded by lacunae, similarly to disc cells in the native NP (Fig. 8A, arrows). 
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The pellet was surrounded by a thin layer of densely packed cells not separated by 
extracellular matrix. The presence of proteoglycans was further confirmed by a colorimetric 
assay for sulfated glycosaminoglycans (GAG) (Fig.  8B). The GAG content remained 
constant up to four weeks after incubation (Fig. 8B). Longer incubation led to an increase of 
the GAG content. Immunodetection of the proliferation marker Ki-67 was negative, 
suggesting that the observed increase of proteoglycans is not due to cell proliferation (data 
not shown). The GAG content of the pellets was approx. 20 times lower than that found in 
native bovine NP tissue (7.9 μg GAG / mg tissue) and 10 times lower when compared to 
bovine AF tissue (4.7 μg GAG / mg tissue).  
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Figure 7. Haematoxylin and eosin staining of a chondrons-based pellet.  
A) Note the round shaped morphology of the pellet culture system. B) Enlargement of the area indicated in 
(A).  
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Figure 8. Presence of proteoglycan in the chondron-based pellet. A) Alcian blue staining of a chondron-
based pellet. Cells were counterstained with Mayer’s hemotoxylin, proteoglycans appear blue. B) 
Proteoglycan content of the chondrons-based pellet culture at indicated time points. Expressed as μg sulphated 
glycosaminoglycans per mg wet weight of the pellet tissue. The experiment was performed on two 
independent samples  (measurements in duplicates) and averages are presented. 
 
 
The presence of collagens was determined after four weeks of incubated pellets by 
Van Gieson staining for collagen type I or by immunohistochemistry for collagen type II. 
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Due to the strong interactions with acidic dyes, type I collagens can be demonstrated more 
selectively with compound solutions of acidic dyes like van Gieson [336]. Staining of 
native bovine disc tissue from the transition zone and the nucleus pulposus revealed intense 
red areas in the transition zone that were absent from nucleus tissue (Fig.  9AB). In the 
pellet we observed the intense red staining exclusively in the outermost cell layer (Fig. 9C), 
suggesting the absence of fibrous collagens inside the pellet. Immunohistochemistry for 
collagen type II in native bovine disc tissue revealed most intense staining in the PCM 
surrounding the disc cells (Fig. 9DE). In the pellet, collagen type II was also detected, but 
the localisation was more outspread (Fig. 9F).  
 
 
Figure 9. Van Gieson and collagen type II-specific immunostaining of the TZ and NP of the IVD and of 
the pellet. Van Gieson staining of the transition zone (TZ) of the bovine IVD (A), nucleus pulposus (NP) (B), 
and pellet (C). Collagen type II DAB immunostaining of the TZ (D), NP (E), and pellet (F). Positive staining 
for collagen type II appears brown; nuclei are counterstained with Mayer’s hematoxylin. 
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Accumulation of CML-modifications after exposure to various environmental conditions. 
CML accumulation was analysed in chondron pellet cultures exposed to environmental 
conditions. Incubation of the pellets in cultivation medium containing the more reactive 
reducing sugar ribose in replacement of glucose to accelerate non-enzymatic glycation 
served as positive control. After 4 weeks of incubation significant accumulation of CML 
was detected (Fig. 10A). The most intense staining was seen in the vicinity of cells, 
especially cell clusters that were present in the pellet. However, the extracellular matrix was 
also often positive. Regions of intense staining were interspersed with cells that did not 
reveal any positive staining. Considerable weaker staining was found in pellets incubated in 
standard culture medium, e.g. DMEM/F12 containing 200 mM glucose. Again, intense 
staining was seen in the vicinity of cells and cell clusters with fainter staining 
intercellularily (Fig. 10B). Hypoxic conditions resulted in a slightly lower intensity as seen 
with the standard medium. However, more cells were found without CML accumulation in 
their immediate vicinity (Fig. 10C). Lowering the pH of the medium to pH 6.7 led to a 
notable reduction of the CML accumulation compared to the standard culture medium. The 
surrounding of the majority of the cells was negative or only very faintly CML positive 
(Fig. 10D). Without glucose in the medium, only a small portion of the cells were positive 
for CML in their vicinity. In intercellular regions only isolated patches were positive for 
CML accumulation. Surprisingly, we noticed the outermost cell layer to be positive (Fig. 
10E). Pellets formed during these conditions typically displayed an irregular shape 
compared to pellets formed under standard conditions. 
 107
                                                                                                                                                                     Results 
Expression of RAGE after exposure to various stress conditions. Since CML accumulates 
inside the pellet cultures under various conditions we examined the presence of the AGE 
receptor RAGE. Treatment of the cultures with ribose instead of glucose resulted in almost 
all cells being positive for RAGE with no staining of the intercellular matrix (Fig. 10G). 
Pellets incubated with standard medium revealed a very similar pattern compared to ribose-
treated cultures, with almost all cells being positive. However, the signal was notably 
weaker than in the positive control (Fig. 10H). Staining was weaker under hypoxic 
conditions with many cells being negative for RAGE (Fig. 10I). Lowering the pH resulted 
in weaker staining compared to the standard medium. However, the staining was more 
intense and more cells were positive compared to the pellets cultivated under hypoxic 
conditions with the most intensely stained cells located towards the outside of the pellet 
(Fig. 10J). Absence of glucose from the medium resulted in disappearance of almost any 
RAGE-positive cell from the pellet. Very few weakly stained cells that were distributed 
randomly among the pellet matrix were identified(Fig. 10K). 
In conclusion,  conditions that led to a strong increase in CML accumulation resulted also in 
a robust presence of RAGE. However, hypoxia appears to result in a notable decrease in 
RAGE expression, whereas a lowered pH of the medium did not have any noteworthy effect 
on RAGE expression. The lack of glucose abolished RAGE presence almost completely 
(summarised in table 1). 
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Figure 10. DAB immunostaning for CML and RAGE of chondron-pellets incubated under various 
stress conditions. Panels A-F and G-L correspond to immunostaining to detect CML and RAGE, 
respectively. Cultivation conditions of the respective pellets are mentioned on the left (A and G: ribose-
containing medium; B and H: standard medium; C and I: hypoxic condition (2% O2; D and J: low pH (pH 
6.7); E and K: no glucose medium; F and L: negative controls without primary antibody). 
 
 
Cell viability after exposure to various cultivation conditions. Assessment of cell viability in 
the pellets incubated under the various cultivation conditions using a TUNEL assay 
revealed significant amounts of dead cells in the pellets (Table 1). The highest proportion of 
dead cells was found when glucose in the cultivation medium was replaced by ribose. 
Under this condition most of the cells were TUNEL-positive (> 90 %). The presence of 200 
mM glucose or the absence of glucose from the medium resulted in a very similar 
proportion of dead cells in the pellets (54 vs. 57 %). Cultivation under hypoxic or low pH 
conditions results in a similar proportion of dead cells (48 vs. 49 %), slightly lower 
compared to cultivation under standard conditions. These results reveal that cultivation of 
disc cells in pellet cultures for 4 weeks results in a substantial reduction of cell viability. 
Pellet cultured for 2 weeks revealed a cell viability >90% (Data not shown). 
 
 Incubation conditions 
 ribose standard hypoxia low pH no glucose 
CML +++++ +++ ++ ++ + 
RAGE +++++ +++ ++ +++ 0 
pellet 
morphology round round irregular Round Irregular 
cell death 
(%)a 92 57 54 48 49 
a average percentage of two independent experiments 
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Table 1: CML accumulation, RAGE expression and pellet morphology of the pellets cultivated under various 
conditions (+++++ = maximal observed intensity, 0 = not detectable). 
 
6.1.3. Materials and methods 
Cell Isolation. Bovine caudal spines were obtained from the local abattoir (age approx. 2 
years) and processed within 3 hours of slaughter. The discs were dissected and the nucleus 
tissue carefully separated from the annulus. Nucleus cells with their pericellular matrix were 
isolated by collagenase/dispase digestion (0.3 % dispase and 0.2 % collagenase w/v in OK 
medium). Digestion was carried out overnight at 37° C (100 % humidity, air, 5 % CO2). 
Digested tissue and medium were filtered with a Falcon 70 μm cell strainer to remove 
undigested fragments, washed three times with OK medium and resuspended in OK 
medium. Viable cells, as determined by Trypan blue exclusion, were counted and diluted to 
1 x 105 cells per ml in DMEM. 5 x 105 cells were transferred to a 15 ml polypropylene 
conical tube (Falcon) and centrifuged at 200 x g to form aggregates. The cultures were 
incubated at 37° C (100 % humidity, air, 5 % CO2) either in OK medium (pH 7.2), acidic 
OK medium (pH 6.7), OK medium in a hypoxic chamber (2% oxygen), DMEM without 
glucose or DMEM without glucose complemented with 30mM D-ribose.  The medium was 
changed after five days and every three days thereafter. 
Materials. OK medium: 50 % DMEM and 50 % F12, 10 % fetal calf serum, 2 mM 
glutamine, 1 % Antibiotic/antimycotic (penicillin, streptomycin, amphotericin B (Life 
Technologies)). DMEM without Glucose containing 10% fetal calf serum, 2 mM glutamine 
and 1 % Antibiotic/antimycotic.  
Collagenase (Sigma), dispase II (Roche Applied Science) and D-ribose (Sigma). 
Ca/Mg-free PBS (PAN Biotech GmbH).  
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Antibodies: the following antibodies were used: rabbit polyclonal antibody to 
collagen type II (Acris Antibodies GmbH), rabbit polyclonal antibody to collagen type VI 
(Acris Antibodies GmbH), rabbit polyclonal antibody to N-(carboxymethyl)-lysine (CML) 
(E. Schleicher, Tübingen) and mouse monoclonal antibody to RAGE (Chemicon 
International). Secondary antibodies used in immunohistochemistry: goat anti rabbit Alexa 
Fluor 488 antibody (Molecular Probes) and biotinylated anti rabbit antibody (Vector 
Laboratories, Inc).  
Histology. Tissue samples were fixed in 3.7% formaldehyde in PBS for 1 day and 
embedded in paraffin. The tissue sections were heated for 1 hour (60°C), deparaffinized in 
xylol and rehydrated through graded ethanol. In addition, samples were taken from the cell 
suspensions yielded after digestion and dried on a Superfrost Ultra Plus® (Menzel GmbH) 
slide and fixed with 3.7% formaldehyde.  
Routine stainings with Alcian Blue (pH 2.5), Haematoxylin & Eosin and Van Gieson were 
performed on 5 μm tissue sections (according to the manufacturers’ recommendations). 
Immunofluorescence staining: Pepsin antigen retrieval (Pepsin Solution, Lab Vision 
Corporation) was performed on 5 μm tissue sections at 37°C for one hour and then rinsed in 
PBS. The slides were blocked in 1 % BSA (Sigma), 0.2 % dry milk powder and 0.1 % 
Tween 20 in PBS for one hour, followed by the incubation of a 1:100 dilution of the 
primary antibody in 1 % BSA and 0.1 % Tween 20 in PBS for one hour. Tissue sections 
were rinsed in PBS and incubated for a further 30 minutes with a 1:400 dilution of the 
secondary antibody in 1 % BSA and 0.1 % Tween 20 in PBS. The slides were rinsed again 
in PBS and counterstained with DAPI (1:1000) in PBS for 15 minutes. Sections were 
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rinsed, mounted with Immu-mount (Shandon) and viewed under the fluorescent 
microscope.  
Immunoenzyme staining: 5 μm tissue sections were incubated in 3% oxygen peroxide for 
10 minutes, washed and then pepsin antigen retrieval was performed at 37°C for one hour. 
Samples were blocked in 10% normal goat serum (Vector Laboratories) and 0.1 % Tween 
20 in PBS for one hour, followed by the incubation of a 1:100 dilution of the primary 
antibody in 1 % normal goat serum and 0.1 % Tween 20 in PBS for one hour. Tissue 
sections were rinsed in PBS and incubated for a further 30 minutes with a 1:200 dilution of 
the secondary antibody in 1 % normal goat serum and 0.1 % Tween 20 in PBS. The slides 
were washed in PBS and incubated for 10 minutes with the Vectastain ABC kit (Vector 
Laboratories) and followed by a further rinse with PBS. The slides were incubated with a 
1:10 dilution of DAB/Metal concentrate (10x) (Pierce) in stable peroxidase substrate buffer 
(1x) (Pierce) until a brown colour appeared which was followed by a further wash with 
PBS. The samples were counterstained with Mayer’s Haematoxylin for 1 minute, washed, 
incubated in 1% HCl/70% ethanol for 3 seconds, rinsed in tap water for 5 minutes and then 
dehydrated and mounted. Unless stated, all incubation and washing steps were performed at 
room temperature. For immunostaining on paraffin-embedded sections with collagen type II 
and VI antibodies, pepsin antigen retrieval (Pepsin Solution, Lab Vision Corporation) at 
37°C for 10 minutes was performed. 
Proteoglycan determination. The proteoglycan contents of the samples were measured as 
sulphated glycosaminoglycan (GAG) by a direct spectrophotometric microassay with 
Dimethylmethylene Blue (DMMB) with chondroitin sulphate from bovine trachea (Fluka 
BioChemica) as a standard. GAG contents were determined in pellets cultivated for 2, 3, 4, 
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5 and 6 weeks under normal conditions. Two independent experiments were performed and 
measured in duplicates. 
Assessment of cell death. Cell death was determined on paraffin sections of pellets 
incubated for 4 weeks using the ‘In Situ Cell Death Detection Kit, POD’ (Roche Applied 
Science). Briefly, the sections were deparaffinised in xylol and rehydrated through graded 
ethanol. The sections were then incubated with nuclease-free proteinase K (Roche Applied 
Science) for 30 min at 25°C. After rinsing in PBS, the sections were incubated with the 
labeling mix for 1 h at 37°C as recommended by the manufacturer. After rinsing in PBS the 
sections were counterstained with DAPI in PBS (1:1000) for 10 min at 25°C. Sections 
treated with DNase I served as positive controls and resulted in > 90 % of dead cells. Two 
independent experiments were performed and at least 300 cells per pellet were counted to 
determine the ratio of life vs. dead cells. 
 
6.2. Detection of RAGE at protein and gene level 
6.2.1. Introduction and aim 
In order to corroborate our immunohistochemistry data, we proceeded to identify 
RAGE at protein and gene expression level in human tissue as we were unable to detect it in 
bovine NP cells as shown in Paper 1.  
6.2.2. Results 
Unfortunately by immunoblotting we were unable to detect RAGE using two 
commercially available antibodies, rabbit polyclonal antibody for RAGE (Anaspec) and 
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mouse monoclonal antibody for RAGE (Chemicon). The mouse monoclonal antibody had 
been used for the immunohistochemistry experiments and had given a positive signal. For 
immunoblotting,  80μg of protein from a human degenerated intervertebral disc was loaded. 
Immunoprecipitation was further performed to analyse the presence of RAGE. Both 
approaches failed and no RAGE could be detected in the human degenerated IVD lysate. 
Human lung tissue served as a positive control for RAGE (Figure 11).  
 
Figure 11. Immunoblotting to detect RAGE in human degenerated IVD and lung tissue. Lysates 
prepared from human lung tissue served as a positive control. RAGE could not be detected in the human 
degenerated IVD biopsy. Ponceau red was applied to check for loading. 
 
Conventional RT-PCR was additionally performed on human lung, and biopsies of 6 
human degenerated IVDs. The positive control was again positive. However RAGE could 
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not be detected in neither of the human degenerated IVDs, even after 40 cycles (data not 
shown).  
Taken together these findings indicate that the RAGE protein is unidentifiable under 
denaturing conditions such as immunoblotting or immunoprecipitation, as well as at mRNA 
level as shown by the RT-PCR. 
6.2.3. Materials and methods 
 The materials and methods are the same to the submitted manuscripts. 
 
6.3. NGF in the intervertebral disc 
6.3.1. Introduction and aim 
Recently, an atypical growth factor has been found inside the human intervertebral 
disc, which is the nerve growth factor (NGF). NGF does not have any known proliferative 
or anabolic functions on disc cells but has been shown to exert neurotrophic properties in 
other tissues.  Additionally, as described by Abe et al. there is a low but constitutive 
expression of NGF and its receptor TrkA in human NP cells [337]. Moreover, both, IL-1β 
and TNF-α, up-regulate its gene expression and protein secretion into the media as well as 
upregulating TrkA expression in NP cells. The exact role of NGF produced by IVD cells in 
the generation of discogenic pain or on the metabolism of IVD cells is not clearly 
elucidated. Furthermore, its presence in degenerated intervertebral disc as described in the 
literature is rather contradictory as NGF has until recently been thought to be produced 
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exclusively by neurons. In a study by Freemont et al., immunoreactivity to NGF was found 
exclusively in pain level discs, whilst non-pain level discs or normal discs were entirely 
negative [338].  
Growth factors are being brought to our attention due to their putative contributions to disc 
degeneration and  pain induction. The aim of this experiment was to analyse NGF at protein 
level in bovine disc cells and to test whether the expression could change in response to a 
specific stimulation: the accumulation of advanced glycation end-products, low pH (6.7) 
and oxidative stress due to peroxynitrite.  
6.3.2. Results 
Immunoblotting analysis has shown the presence of the precursor form of NGF in 
bovine nucleus pulposus cells. In whole cell extracts, no changes on expression were 
detected upon stimulation for either 40 minutes, 3 or 6 hours (data not shown). However, 
cytoplasmic extracts prepared from bovine NP cells stimulated for 40 minutes did show an 
increase in the NGF precursor form when bovine NP cells were stimulated with either low 
pH, SIN-1 (i.e. stable peroxynitrite donor) and TNF-α (Figure 12).  
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Figure 12. NGF expression in bovine NP cells. Cytoplasmic extracts of bovine NP cells stimulated for 40 
minutes under different conditions. A 65kDa band corresponding to p65(RelA) can be detected which served 
as a control. Typically, p65(RelA) should be cytoplasmic in unstimulated cells, upon stimulation like with 
TNF-α, p65(RelA) translocates into the nucleus even though a pool of p65(RelA) still remains in the 
cytoplasm. 40μg of cytoplasmic fraction was loaded (based on Ponceau red staining). The precursor form of 
NGF can be detected at 32kDa under certain conditions.  
 
 
6.3.3. Materials and methods 
 The materials and methods are the same to the submitted manuscripts. 
 
6.4. Influence of hypoxia (0.2% oxygen), low pH (6.7) and SIN-1 on bovine NP cells 
 
6.4.1. Introduction and aim 
The intervertebral disc is the largest avascular tissue in the human body. Although 
some vascularisation of the disc exists during the fetal and infantile stages of life, the tissue 
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becomes avascular during youth and remains this way thereafter. The blood vessels 
originating in the vertebral body and originally reaching into the disc, terminate right above 
the cartilage EP, leaving the disc cells without direct supply [339, 340]. Oxygen and 
nutrients need to diffuse from the capillaries of the vertebral bodies through the EP and disc 
matrix into the nucleus of the disc, while waste diffuses in a same manner, outwards. 
Measurements of oxygen and lactic acid concentrations in IVDs of patients suffering from 
low back-pain or scoliosis showed that lactic acid accumulates with increasing distance 
from the boundary of the disc [341]. Whilst oxygen concentrations were very low in the 
nucleus and increased towards the disc surface, the lactic acid concentration showed a 
reverse profile. Lactic acid is not only the major waste of disc cells, but it is an acid and 
thus able to lower the pH inside the IVD. In vitro experiments have shown that low oxygen 
concentrations and an acidic pH significantly affect the activity of disc cells. Matrix 
synthesis rates were observed to decrease significantly and cell viability was also adversely 
affected [342].  
These preliminary experiments aimed to examine the pro-inflammatory cytokine profile in 
bovine NP cells under a hypoxic environment (0.2% oxygen) using the same set up as in 
Paper 1 (section 5.1.) (Figure 13), or in an acidic environment, i.e. media with a pH = 6.7, 
or oxidative stress caused by peroxynitrite using the stable peroxynitrite-donor SIN-1 
(1mM) (Figure 14).   
 
6.4.2. Results 
These preliminary experiments indicated that hypoxia induces changes in the 
expression profile of IL-1β only as shown in Figure 13 especially at 6 hours with CML-
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BSA. There were no changes for either IL-6 (Figure 13) or TNF-α (data not shown) 
expression. Obviously, a dramatic decrease oxygen tension down to 0.2% oxygen greatly 
affects IL-1β expression levels in the presence of the advanced glycation end products, 
CML, which has huge consequences in ECM remodelling processes. With regard to the 
oxygen tension, the centre of the NP region of the IVD has relatively low levels of oxygen 
(as shown in Fig. 2); nevertheless a further decrease due to possible EP calcification might 
be rather detrimental in trying to endure ECM homeostasis.  
    
 
 
Figure 13. Pro-inflammatory cytokine profile under hypoxia of bovine nucleus pulposus cells stimulated 
with AGE/CML-BSA. All experiments were performed under hypoxic conditions at 0.2% oxygen. The 
cytokine profile for IL-6 and IL-1β was analysed using quantitative real-time RT-PCR. NP cells were 
stimulated with either AGE/CML-BSA. On the y and x axis the fold increase and the time point in hours is 
represented, respectively. Expression levels were expressed in arbitrary units, setting the untreated value as 1. 
The values were normalised relative to the reference gene S18 protein mRNA to compensate for differences in 
cDNA loading. This figure represents a mean of at two independent biological samples. 
 
An environmental acidic pH or the damage caused by the oxidising agent, 
peroxynitrite, induces changes only in IL-1β gene expression. Instead, IL-6 (Figure 14) and 
TNF-α (data not shown) remained again unchanged. These results indicate that both stimuli 
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are inducing the pro-inflammatory cytokine IL-1β mainly implying that IL-1β may be key 
in the degenerative processes occurring in the IVD. 
 
Figure 14. Pro-inflammatory cytokine profile of bovine nucleus pulposus cells stimulated with a low 
environmental pH (6.7) and SIN-1. All experiments were performed under normoxic culturing conditions. 
The cytokine profile for IL-6 and IL-1β was analysed using quantitative real-time RT-PCR. NP cells were 
stimulated with either a media with pH 6.7 or by 1mM of SIN-1. On the y and x axis the fold increase and the 
time point in hours is represented, respectively. Expression levels were expressed in arbitrary units, setting the 
untreated value as 1. The values were normalised relative to the reference gene S18 protein mRNA to 
compensate for differences in cDNA loading. This figure represents a mean of at three independent biological 
samples. 
 
 
6.4.3. Materials and methods 
 The materials and methods are the same to the submitted manuscripts. 
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6.5. Effects of short and long-term peroxynitrite stimulation in nuclear shuttling of 
NFκB/p65 
6.5.1. Introduction and aim 
Preliminary immunofluorescence experiments were performed to determine the 
prolonged effects on nuclear translocation of NF-κB/p65 by the peroxynitrite donor SIN-1 
(1mM) on human NP cells. TNF-α (10ng/ml) was chosen as a positive control for the 
transient canonical NF-κB pathway.   
6.5.2. Results 
At 40 minutes immunofluorescence microscopy showed nuclear translocation of 
p65(RelA) upon TNF-α (10ng/ml) stimulation whereas only a few NP cells had a nuclear 
staining for p65(RelA) when treated with SIN-1. In contrast, at 14 hours, the pattern 
changed, as in TNF-α treated cells, staining was mainly cytoplasmic, while the majority of 
SIN-1 stimulated cells had a nuclear as well as cytoplasmic staining for p65(RelA). The 
staining for both time points in unstimulated cells was mostly cytoplasmic. Even though the 
morphology of the cells changed a bit due to the starvation of these cells during the time of 
stimulation, i.e. no serum was added to the media, cell viability was >90% as detected by 
Calcein-AM and Ethidium Homodimer staining.  
These results indicate that peroxynitrite is involved in a prolonged nuclear translocation of 
p65(RelA) which could potentially be activated and be involved in chronicity or prolonged 
inflammatory processes.  
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Figure 14. Detection of p65(RelA) in human NP cells by immunofluorescence. Human NP cells were 
stimulated for 40 minutes or 14 hours with either TNF-α (10ng/ml) or SIN-1 (1mM). Red staining 
corresponds to p65(RelA), the nucleus of the cells were counterstained with DAPI (blue). The experiment was 
performed in cells from degenerated NP cells from two different donors (n=2).   
 
6.5.3. Materials and methods 
 The materials and methods are the same to the submitted manuscripts. 
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6.6. Human telomerase reverse transcriptase (hTERT) in NP cells 
 
6.6.1. Introduction and aim 
In vitro culture systems are urgently required to permit the study of the molecular 
processes leading to IVD degeneration and ultimately, pain. Unfortunately, the slow rate of 
growth, the halt in growing cultures after a certain passage and the differentiation processes 
of human NP cells associated to monolayer culture, greatly hamper experiment. In fact, 
human NP cells have been reported to arrive to a senescence state at approximately passage 
20 [343]. 3-D systems permit the circumvention of differentiation problems; however, these 
systems involve a limited number of cells and the ‘noise’ produced by the introduction of 
foreign matter.  
A recent tool to immortalise human NP cells is the overexpression of the human telomerase 
catalytic subunit (hTERT) [344, 345]. Immortalisation of cells with hTERT has an 
advantage over viral proteins. The viral immortalisation mediators display oncogenic 
properties, such as inactivation of the major tumour suppressor proteins [346];  hTERT 
solely elongates chromosomal ends, which prevents genomic catastrophe or crisis 
associated with cell death [347]. It is well accepted that early passage hTERT-immortalised 
cells, for instance in propstate stromall cells 90 passages, faithfully represent the 
physiologic properties of normal cells in vivo [348].  
Thus, this strategy was chosen to set a ready pool of human NP cells which will maintain 
their phenotype when cultured in monolayer and which might still be grown after passage 
20. This would also help the reproducibility of our experiments. Otherwise the biopsies 
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obtained from the clinic correspond to a wide spectrum of aged-patients with a wide variety 
of pathologies.    
 
6.6.2. Lentivirus containing hTERT 
For the generation of viruses a total of 4x106 HEK 293T cells were seeded in 10cm 
dishes 24 hours prior to transfection. Viral stocks were prepared by transient transfection of 
HEK 293T cells with 3.5μg of the envelope plasmid, 6.5 μg of packaging plasmid, and 
10μg of transfer vector using Calcium phosphate precipitation method (Plasmids used: 
Protein G, NGVL gag pol, and the pOS containing hTERT vector, respectively). The 
medium of HEK 293T cultures was replaced 5 hours post-transfection and conditioned 
medium was collected after another 24 hours, filtered through a 0.45μm cellulose acetate 
filters. Freshly harvested conditioned medium was used to infect 1.5x105 NP cells in a six-
well plate in the presence of polybrene (4μg/ml) (Sigma, Switzerland).  
This protocol was adopted from [349]. Cells were passaged twice and analysed by 
immunofluorescence to check for GFP incorporation, followed by FACS sorting. Positive 
and negative GFP containing cells were further plated to expand. Retroviral pOS vectors 
were kindly provided by Prof Zimmermann (Freiburg, Germany). 
The source of NP cells came from two donors: a sequestered-herniated IVD from a 40-year-
old male, and a young IVD from a 14-year-old boy with spinal fracture which would 
otherwise be considered healthy.  
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Figure 16. Retroviral pOS vectors containing hTERT. a) Schematic diagram of the pOS vectors. b) 
Immunofluorescence due to GFP of the 40-year-old IVD cells representing the success upon transfection with 
the lentivirus containing the pOS vectors. The first column corresponds to the untransfected cells. Same 
pictures were obtained for NP cells of the 14-year-old donor.   
 
 
6.6.3. Results  
The cells had a transfection rate which varied from 5 to 10%. Transfected cells with the 
retroviral pOS vectors immunofluoresced green for GFP (Figure 16). This is an ongoing 
project. NP cells were further expanded until passage 5 and handed over to Dr. Wuertz. 
Phenotypic characterisation and telomere length measurement will be assessed in the near 
future.  
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DISCUSSION 
 
7. Summary of results 
 Experimental evidence presented in this thesis identified putative mechanisms 
involved in the degenerative processes possibly occurring in the ageing disc by the action of 
oxidative stress. This involves post-translational modifications: advanced glycation end 
products (AGEs) and tyrosine nitration mediated by peroxynitrite.  
 The first paper provides evidence for the role of AGEs in the ECM 
remodelling/disruption processes as shown in the NF-κB-dependent metalloproteinase 
MMP-13. Although the examined AGE receptors were not affected by its ligands 
AGE/CML in the bovine model; on AGE stimulation NF-κB/p65 nuclear translocation 
occurred, implying the putative activation of an NF-κB-dependent pathway in the IVD.  
 In the second paper, tyrosine nitration was observed in human NP cells from 
degenerated IVDs. Tyrosine nitration is a marker for peroxynitrite, which is a highly 
reactive agent formed in vivo from the interaction of superoxide and NO. Both, 
peroxynitrite and SIN-1 (a stable peroxynitrite donor) induced nitrosylation in NP cells as 
well as the activation of a prolonged NF-κB-dependent signalling pathway, resulting in the 
upregulation pro-inflammatory cytokines IL-1β, IL-6 and IL-8. The prolonged nuclear 
shuttling of NF-κB by peroxynitrite in NP cells might be indicative of its putative 
involvement in a chronic inflammation.  
 The unpublished results provide a characterisation of the chondron-pellet system 
indicating its limitations for experimental use in cell number and time viability course. 
Additionally, human NP cells were infected with a lentivirus containing hTERT, in order to 
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develop a human NP pool of cells to use in future experiments which do not readily 
differentiate. hTERT should elongate the telomeric ends allowing a higher passage number; 
nevertheless, this is part of an ongoing project which will require phenotypic 
characterisation of these NP cells in the future.  
Taken together, the results presented in this thesis provide further evidence that NF-κB 
activation is central and can potentially influence ageing/degeneration processes in the IVD 
through AGE accumulation or peroxynitrite action. 
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8. A chondron-based pellet culture system of bovine NP cells. 
Initially, we attempted to establish a 3-D system which could potentially be used for 
our intended experiments because of the shortcomings of 2-D systems as discussed in 
section 1.5.1. Nevertheless, after encountering significant limitations with our best choice of 
3-D culture system, we decided to change our approach by culturing IVD cell in monolayer 
culture limiting the passage number of the cells to 4. The corresponding phenotypic 
characterisation was performed to ensure that the phenotypic markers were still expressed. 
 
8.1. Use and limitations 
Since it has been shown that disc cells require a three-dimensional cultivation 
system in order to maintain their phenotype, a modification of the carrier-free pellet culture 
system in this study was applied. Based on the original pellet culture system presented by 
Yung Lee et al. [146], we assumed that the inclusion of the native PCM of the IVD cell in 
the pellet formation process may further ensure the conservation of the native cell 
phenotype. From studies on articular cartilage, the concept of the ‘chondron’, i.e. the 
chondrocytic cell surrounded by the PCM, has been established [146, 334]. Therefore, we 
applied a pellet culture system that combines the advantages of the original pellet system 
with the chondron concept. In our approach, we made use of the easy availability of bovine 
coccygeal nucleus pulposus cells that have been shown to display a cellular phenotype 
similar to their human counterparts [148, 332]. Histology demonstrated that disc cells 
cultured in this system shared properties with the native disc cell phenotype, i.e. low 
collagen type I expression, collagen type II expression and presence of proteoglycans. 
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Dedifferentiation was characterised by alterations of the morphological appearance of the 
cells and the presence of the fibrillar collagens in the outer rim and after prolonged 
incubation. Taken together, the histology data suggest the chondron-based pellet system 
might be a suitable model to culture disc cells in vitro, even though the number of cells that 
can be used per pellet is rather limited, hampering the range of experiments that can be 
performed.  
To accelerate CML formation in the pellet culture, glucose in the standard cultivation 
medium was replaced by ribose, a more reactive carbohydrate that has been shown to react 
spontaneously with amino groups on proteins to form AGEs [350]. The presence of ribose 
in the medium led to a pronounced accumulation of CML in the pellet matrix. Accordingly, 
the highest levels of RAGE were also observed in pellets cultured in the presence of ribose.  
Under these conditions we found that the majority of the cells in the pellets were dead at the 
end of the experiment after 4 weeks of incubation (> 90 %). Thus, it can be postulated that 
ribose exerts adverse effects on NP cells. In pellets incubated in standard medium, slightly 
reduced levels of CML and RAGE were found compared to the ribose treated cultures. 
Considering the significantly lower reactivity of glucose compared to ribose, a substantially 
lower accumulation of CML in the matrix is to be expected. It is conceivable that the high 
glucose concentration present in the normal culture medium induces intracellular reactive 
oxygen species (ROS) as seen with diabetic complications [351]. ROS might not only be 
responsible for the substantial CML and RAGE levels but might also lead to apoptosis of 
the cells which explains the high percentage of dead cells (approx. 50 %). In the absence of 
glucose in the culture medium, CML accumulation and RAGE expression decreased 
dramatically and were hardly detectable. Culture under hypoxic or acidic conditions in the 
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presence of glucose resulted in CML accumulation and RAGE expression that was more 
pronounced than under glucose-free cultivation conditions but reduced in comparison with 
the standard conditions. The decreased CML and RAGE levels under hypoxic or acidic 
conditions might be interpreted as a protective effect of low pH and pO2 hindering CML 
accumulation in the presence of high glucose levels. However, culture under hypoxic, acidic 
and no-glucose conditions resulted in approximately 50 % of dead cells in the pellets. The 
poor cell survival under all applied cultivation conditions suggests that the chosen 
cultivation period is too long. Further experiments with shorter incubation periods should 
allow determination of CML accumulation and RAGE expression at a time point when the 
majority of the cells are still alive. 
 Preliminary experiments have indicated  a 90% viability of cells under most conditions at 2 
weeks incubation, implying that a shorter incubation may be desirable for the use of 
chondron-pellet culture system. Although the cell survival in this setup needs to be 
improved, these data suggest that CML accumulation and RAGE expression can be 
modulated by the applied culture conditions. It is important to keep in mind that cell 
viability has only been determined at the end of the experiment after four weeks of 
incubation. Therefore, we do not yet have any information about the time course of cell 
death. Substantial differences in CML accumulation and RAGE expression with 
comparable levels of cell death might suggest that the environmental condition caused CML 
accumulation and RAGE expression earlier during the experiment, when the cell were still 
alive. Experiments with shorter incubation periods should further clarify the time course of 
CML accumulation and RAGE expression versus cell death. 
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8.2. Perspectives 
Nevertheless, the above data on RAGE immunohistochemistry has to be carefully 
taken into account as we could not detect RAGE by immunoblotting or 
immunoprecipitation. It could not even be detected by RT-PCR. Both antibodies used in 
these experiments can detect non-denatured and denatured proteins. Various possible 
explanations include:, i) the mouse monoclonal antibody for RAGE from Chemicon might 
have been isolated with some other protein, as a high molecular weight is observed in 
bovine lung (approx. 150kDa), or ii) that RAGE itself is glycosylated i.e. incrementing its 
size, iii) that RAGE itself dimmerises or forms some kind of non-covalent complexes, or 
finally iv) in the case of the bovine RAGE there is a high molecular weight splice variant. 
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9. Role of AGEs in disc matrix homeostasis and remodelling processes. 
 
9.1. ECM remodelling 
Advanced glycation end products (AGEs) result from non-enzymatic glycation of 
the amino groups of proteins with reducing sugars such as glucose. During normal ageing, 
but also at a higher rate during complications involving inappropriate sugar reabsorption 
such as diabetes, AGEs accumulate on long-lasting proteins such as collagens and elastins.  
The formation of AGEs on collagen favours its cross-linking, resulting in a decreased 
degradability by, e.g., matrix metalloproteinases (MMPs), and impairing their regeneration. 
Collagen metabolism is a complex process requiring balanced synthesis and degradation by 
ECM-remodelling enzymes and the action of cytokines. In our study we analysed the 
influence of AGEs in NP cells by examining receptor profile, pro-inflammatory cytokine 
gene expression, nuclear translocation of NF-κB/p65 and their influence on a key 
degradative enzyme, MMP-13. Receptor and cytokine expression did not vary upon 
stimulation with AGEs. Nuclear translocation NF-κB/p65 was indeed observed and MMP-
13 expression was largely enhanced. Thus, our results indicated that AGEs may induce an 
NF-κB-dependent pathway and target genes comprising ECM-remodelling enzymes. Even 
though, it should be noted that a direct link between NF-κB and MMP-13 was not analysed, 
MMP-13 has been reported to be a NF-κB-dependent gene and was even reported to be 
upregulated in degenerated IVD [352].. 
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These findings suggest that due to AGE accumulation in long-lived-ECM proteins, possibly 
causing tissue brittleness and stiffness to the tissue, the cells in the IVD might be trying to 
counteract this by producing a surplus of MMP-13. This would then lead to a shift towards 
catabolic processes. Nevertheless, this might not sufficient or effective in restoring the 
natural properties and function of the ECM of the IVD. A reverse effect might even occur 
due to this surplus of MMP-13 being produced, as it might induce the degradation of other 
healthy collagens. 
 
9.2. Perspectives 
AGEs accumulate in aging/degenerative tissues including the IVD. This 
accumulation is enhanced under certain pathologies involving sugar excesses as in diabetes 
mellitus. 
The effects exerted by these post-translational modifications on ECM-long-lasting proteins 
are obvious as it renders the tissue stiff and brittle, leading to a loss of function, i.e. unable 
to withstand and distribute forces. Undoubtedly, the accumulation of AGEs is a well-
established and important feature of age-related IVD. 
With regard to a receptor-mediated pathway, we were able to identify three receptors which 
have been reported to form the so-called AGE-receptor complex. Although their expression 
did not vary upon stimulation, further experiments analysing the interaction between AGEs 
and the AGE-receptor complex remain to be performed. Contrary to previous publications 
[353, 354], RAGE i.e. the best characterised AGE receptor, which has a tissue specific 
distribution, could not be detected under the conditions tested..Additionally, Schmitt et al. 
identified up to 10 proteins which could bind to AGEs [355]. For instance, it has been 
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reported that only a partial reduction of AGE-stimulated NO and chemokine release can be 
obtained by blocking RAGE [356]. Thus, the total binding of AGEs to cell surface proteins, 
and not only the binding to RAGE, might be important for mediating AGE-effects on cells. 
So, if ligand binding interactions with the AGE-receptor complex fail, it is possible that 
unidentified AGE-receptors are signalling in NP cells.  
A useful in vivo model to study the overall effects of AGEs on IVD cells might be the next 
step to proceed, as in vitro experiments are rather limiting only allowing the analysis of 
certain parameters. In vivo models that would enable the analysis of more profound effects 
involving pain induction and/or sensitation of the dorsal root ganglion may involve the sand 
rat or other diabetic animal models as discussed in section 1.2.3. Of course these models are 
not the best, since many metabolic disorders accompany diabetes mellitus, but they imply 
an enhanced accumulation of AGEs in the IVD at a younger age. Additionally, the sand rat 
has already reported in the literature to have very similar degenerative changes to humans 
[357].  
AGEs seem to be an important feature in age-related changes. However our results indicate 
that AGEs may not be involved in the pro-inflammatory pathways in the IVD. Instead 
AGEs may be disturbing the ECM properties of the IVD leading to a loss of function. 
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10. Peroxynitrite induces cytokine gene expression in human IVD cells 
 
10.1. Peroxynitrite and the activation of an alternative NF-κB signalling pathway. 
The constitutive nuclear translocation due to peroxynitrite or SIN-1 treatment could 
be observed by immunofluorescence up to 14 hours. This prolonged mode of action is in 
accordance to recent data that demonstrate that prolonged exposure to peroxynitrite and/or 
other reactive nitrogen species continuously activates NF-κB through tyrosine nitration of 
IκB, leading to inhibited degradation by the ubiquitin-proteasome pathway [302]. The 
intracellular formation of peroxynitrite from extracellular NO was shown to be crucial for 
the activation of NF-κB by NO [304]. Recently, NF-κB has been linked to the activation of 
different intracellular and extracellular proteolytic systems under conditions of nitrosative 
stress [290]. Hence, this continuous and long-term activation of NF-κB may exacerbate the 
inflammatory responses mediated by this transcription factor. This was shown for various 
cell types including muscle myoblasts and epithelial cells [302, 321].  
By site-directed mutagenesis, tyrosine 181 was identified as the main nitrosylated residue in 
IκBα. IκBα tyrosine 181 nitration leads to dissociation of IκBα from NF-κB [321]. This 
mechanism does not require IκBα kinase (IKK) dependent phosphorylation or proteolytic 
degradation. The importance of tyrosine 181 is its ability to stabilise the IκBα-NF-κB 
complex through non-covalent interactions with the p50 subunit as shown by the crystal 
structure[321]. Thus, tyrosine nitration becomes an important post-translational 
modification involved, in this case, in an aberrant NF-κB activation. 
 
 
 136
                                                                                                                                                               Discussion 
10.2. Target genes of peroxynitrite. 
 The genes affected by peroxynitrite consist of a wide spectrum of target genes which 
include matrix remodelling proteins (MMPs and TIMPs) and pro-inflammatory cytokines 
among others. Our target genes of interest in these particular experiments were pro-
inflammatory cytokines as they have long been implicated in disc degeneration or pain.  
Oscillatory wave curves were detected for three NF-κB-dependent cytokines such as IL-1β, 
IL-6 and IL-8, indicating that even though NF-κB might be a shared transcription factor for 
these genes, the recruitment onto the promoter, its accessibility and the involvement of 
various co-regulators might be rather different, leading to time differences. NF-κB activity 
itself was not directly analysed. Nevertheless, nuclear shuttling of p65(RelA) was analysed 
as it might be an indicative of an NF-κB-dependent pathway, since in an inactive state, 
p65(RelA) is mostly retained cytoplasmic.  
The analysis of matrix remodelling proteins might be another interesting mechanism 
induced by peroxynitrite as this compound formed in vivo might exert detrimental effects on 
tissue homeostasis. Thus, peroxynitrite could potentate age and enhance degenerative 
processes in the IVD.  
 
10.3. Perspectives 
Peroxynitrite and other RNS and ROS arise as a very reactive group of components 
that can induce severe detrimental effects in a biological system. Due to their low molecular 
weight they can readily cross cell membranes without limiting the damage that they can 
exert, since not only exogenous but especially endogenous components can be affected. The 
action of peroxynitrite was implicated in many cellular processes ranging from DNA 
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damaging to the constitutive activation of transcription factors as in the case NF-κB. The 
use of antioxidants or anti-nitrosylating might pose a new therapeutic approach the 
treatment of degenerative or inflammatory diseases.   
The maintenance of an oxidative redox equilibrium might be indeed crucial. Oxidative 
stress may not only arise from an excess of reactive oxygen/nitrogen species arising from 
cellular metabolism, but also due to the hampering of appropriate detoxifying agents. 
Genetic epidemiological studies indicated that there are polymorphisms in the gene 
encoding vitamin D receptor which correlated with IVD degeneration [58, 59]. So far, little 
research, has tackled the issue on detoxifying cellular mechanisms in the IVD. Mutations 
might not be the only factor influencing the anti-oxidant enzymes and receptors. The 
shifting towards an oxidative stress may also arise from environmental factors such as a 
dysfunction in nutrition and diffusion of metabolites. Apart from the diffusion of glucose, 
an impaired nutrition affects many other small molecules such as vitamins e.g. anti-
oxidants, minerals, and salts among others; all of which are required for regular cell 
function. In addition, an acidic pH might induce a dysfunction in the cellular metabolism 
leading to an increase in oxidative metabolites. Furthermore, a drop in anti-oxidants and a 
malfunction of their receptors could even lead to cellular senescence. In summary, an 
insight in the anti-oxidant mechanisms of a cell might be determinant in dealing with IVD 
degeneration; i.e. being decesive when the reversal of degenerative alterations and 
subsequent  pain come into focus for therapeutic purposes. 
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